1
|
Muscogiuri G, Kohler L, Parra O, Soltani L, Spegman D, Coletta D, Mandarino LJ. Longitudinal study of the impact of the COVID-19 pandemic on diet and physical activity among Latinos of Mexican ancestry. J Transl Med 2024; 22:342. [PMID: 38594708 PMCID: PMC11005240 DOI: 10.1186/s12967-024-05007-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2024] [Accepted: 02/18/2024] [Indexed: 04/11/2024] Open
Abstract
BACKGROUND The COVID-19 pandemic caused societal disruption in the United States and most of the world, affecting many aspects of life, including healthcare and health-related behaviors such as diet, food security, and physical activity. Communities with economic and health disparities may have been particularly affected. This study was undertaken to determine how conditions in the early pandemic (January, 2021-February, 2022) affected Latino patients of Mexican Ancestry at high risk of type 2 diabetes mellitus who participated in El Banco por Salud biobank project in Tucson, Arizona. METHODS Baseline, prepandemic measurements were available in 17, 21, and 60 patients with normal hemoglobin A1c (HbA1c), prediabetes, and type 2 diabetes, respectively. RESULTS People with healthy HbA1c were significantly younger, less obese, and had higher HDL cholesterol. HbA1c was unaffected by the pandemic in any group. Triglycerides, total and HDL cholesterol levels fell in all groups during the pandemic. Physical activity levels in all groups were remarkably low, with most reporting no engagement in any voluntary physical activity. Engagement in physical activity or its enjoyment was lower in patients with diabetes and prediabetes than in younger, less obese patients. Major diet differences were between men and women and were present before the pandemic. Women consumed significantly more vegetables, fruit, and salad than men. The only pandemic-related change in diet was a drop in egg consumption, possibly explaining the fall in total cholesterol. CONCLUSION Societal disruption during the COVID-19 pandemic had minimal effects on adverse health-related behaviors, cardiometabolic risk, or changes in glycemic control in a Latino community with diabetes and healthcare disparities in the Southwest US.
Collapse
Affiliation(s)
- Giovanna Muscogiuri
- Dipartimento di Medicina Clinica e Chirurgia, Unità di Endocrinologia, Diabetologia e Andrologia, Università degli Studi Di Napoli Federico II, Naples, Italy
- Cattedra Unesco "Educazione alla salute e allo sviluppo sostenibile", University Federico II, Naples, Italy
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA
| | - Lindsay Kohler
- Department of Health Promotion Sciences, College of Public Health, University of Arizona, Tucson, AZ, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, University of Arizona, Tucson, AZ, USA
- Pima County Department of Public Health, Tucson, AZ, USA
| | - Oscar Parra
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, University of Arizona, Tucson, AZ, USA
| | | | | | - Dawn Coletta
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, University of Arizona, Tucson, AZ, USA
- Department of Physiology, University of Arizona, Tucson, AZ, USA
| | - Lawrence J Mandarino
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA.
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, University of Arizona, Tucson, AZ, USA.
| |
Collapse
|
2
|
Corenblum MJ, McRobbie-Johnson A, Carruth E, Bernard K, Luo M, Mandarino LJ, Peterson S, Sans-Fuentes MA, Billheimer D, Maley T, Eggers ED, Madhavan L. Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons. Prog Neurobiol 2023; 229:102501. [PMID: 37451330 DOI: 10.1016/j.pneurobio.2023.102501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2023] [Revised: 06/29/2023] [Accepted: 07/10/2023] [Indexed: 07/18/2023]
Abstract
Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they differed in their nature and scale. Furthermore, statistical analysis revealed potential novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
Collapse
Affiliation(s)
- M J Corenblum
- Department of Neurology, University of Arizona, Tucson, AZ, United States
| | - A McRobbie-Johnson
- Physiological Sciences Graduate Program, University of Arizona, Tucson, AZ, United States
| | - E Carruth
- Physiology Undergraduate Program, University of Arizona, Tucson, AZ, United States
| | - K Bernard
- Physiological Sciences Graduate Program, University of Arizona, Tucson, AZ, United States
| | - M Luo
- Department of Medicine, University of Arizona, Tucson, AZ, United States
| | - L J Mandarino
- Department of Medicine, University of Arizona, Tucson, AZ, United States
| | - S Peterson
- Statistical Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, United States
| | - M A Sans-Fuentes
- Statistical Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, United States
| | - D Billheimer
- Statistical Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, United States
| | - T Maley
- Physiological Sciences Graduate Program, University of Arizona, Tucson, AZ, United States
| | - E D Eggers
- Departments of Physiology and Biomedical Engineering, University of Arizona, Tucson, AZ, United States
| | - L Madhavan
- Department of Neurology, University of Arizona, Tucson, AZ, United States; Evelyn F McKnight Brain Institute and BIO5 Institute, University of Arizona, Tucson, AZ, United States.
| |
Collapse
|
3
|
Zapata Bustos R, Coletta DK, Galons JP, Davidson LB, Langlais PR, Funk JL, Willis WT, Mandarino LJ. Nonequilibrium thermodynamics and mitochondrial protein content predict insulin sensitivity and fuel selection during exercise in human skeletal muscle. Front Physiol 2023; 14:1208186. [PMID: 37485059 PMCID: PMC10361819 DOI: 10.3389/fphys.2023.1208186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Accepted: 06/16/2023] [Indexed: 07/25/2023] Open
Abstract
Introduction: Many investigators have attempted to define the molecular nature of changes responsible for insulin resistance in muscle, but a molecular approach may not consider the overall physiological context of muscle. Because the energetic state of ATP (ΔGATP) could affect the rate of insulin-stimulated, energy-consuming processes, the present study was undertaken to determine whether the thermodynamic state of skeletal muscle can partially explain insulin sensitivity and fuel selection independently of molecular changes. Methods: 31P-MRS was used with glucose clamps, exercise studies, muscle biopsies and proteomics to measure insulin sensitivity, thermodynamic variables, mitochondrial protein content, and aerobic capacity in 16 volunteers. Results: After showing calibrated 31P-MRS measurements conformed to a linear electrical circuit model of muscle nonequilibrium thermodynamics, we used these measurements in multiple stepwise regression against rates of insulin-stimulated glucose disposal and fuel oxidation. Multiple linear regression analyses showed 53% of the variance in insulin sensitivity was explained by 1) VO2max (p = 0.001) and the 2) slope of the relationship of ΔGATP with the rate of oxidative phosphorylation (p = 0.007). This slope represents conductance in the linear model (functional content of mitochondria). Mitochondrial protein content from proteomics was an independent predictor of fractional fat oxidation during mild exercise (R2 = 0.55, p = 0.001). Conclusion: Higher mitochondrial functional content is related to the ability of skeletal muscle to maintain a greater ΔGATP, which may lead to faster rates of insulin-stimulated processes. Mitochondrial protein content per se can explain fractional fat oxidation during mild exercise.
Collapse
Affiliation(s)
- Rocio Zapata Bustos
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, AZ, United States
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ, United States
| | - Dawn K. Coletta
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, AZ, United States
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ, United States
- Department of Physiology, The University of Arizona, Tucson, AZ, United States
| | - Jean-Philippe Galons
- Department of Medical Imaging, The University of Arizona, Tucson, AZ, United States
| | - Lisa B. Davidson
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, AZ, United States
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ, United States
| | - Paul R. Langlais
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, AZ, United States
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ, United States
| | - Janet L. Funk
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, AZ, United States
| | - Wayne T. Willis
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, AZ, United States
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ, United States
| | - Lawrence J. Mandarino
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, AZ, United States
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ, United States
| |
Collapse
|
4
|
Standage-Beier CS, Garcia LA, De Filippis E, Shaibi GQ, Mandarino LJ, Coletta DK. Association of Vitamin D Receptor Gene Polymorphisms with Cardiometabolic Phenotypes in Hispanics: A Life Course Approach. Nutrients 2023; 15:2118. [PMID: 37432296 PMCID: PMC10180542 DOI: 10.3390/nu15092118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 04/25/2023] [Accepted: 04/26/2023] [Indexed: 07/12/2023] Open
Abstract
The vitamin D receptor (VDR) is vital for maintaining calcium and phosphate balance and regulating bone metabolism. Recent research has suggested that VDR also plays an essential role in metabolic diseases. Previous studies on non-Hispanic whites have shown that VDR single nucleotide polymorphisms (SNP) are associated with cardiometabolic phenotypes. However, the association between VDR SNPs and cardiometabolic traits in Hispanics remains unclear. This study investigated the association between VDR SNPs and cardiometabolic phenotypic data in self-reported Hispanics (n = 1610) from the Arizona Insulin Resistance registry and Sangre Por Salud Biobank. The study population was predominantly female (66.4%) with a mean age of 40 ± 14 years (n = 121 <18 years) and an average body mass index (BMI) of 29.8 ± 6.3 kg/m2. We performed a genotyping association analysis of VDR SNPs (Taq1-rs731236, Fok1-rs2228570 and Apa1-rs7975232) with cardiometabolic traits using linear regression models. The results showed that Taq1 and Apa1 were strongly associated with systolic blood pressure (SBP) in children (<18 years), while Fok1 was associated with measures of adiposity, including fat mass, waist circumference, and BMI. In age-stratified adult (≥18 years) models, Taq1 was strongly associated with hemoglobin A1c, while Apa1 was associated with BMI and fasting glucose. Fok1 had no significant associations in the adult models. In conclusion, the VDR SNPs were associated with several cardiometabolic phenotypes in this Hispanic sample, but the type and strength of the associations varied by age group.
Collapse
Affiliation(s)
| | - Luis A. Garcia
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (L.J.M.)
| | - Eleanna De Filippis
- Division of Endocrinology, Metabolism and Diabetes, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA;
| | - Gabriel Q. Shaibi
- Center for Health Promotion and Disease Prevention, Arizona State University, Phoenix, AZ 85004, USA;
| | - Lawrence J. Mandarino
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (L.J.M.)
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA
| | - Dawn K. Coletta
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (L.J.M.)
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA
- Department of Physiology, University of Arizona, Tucson, AZ 85724, USA
| |
Collapse
|
5
|
Mandarino LJ, Willis WT. Can non-equilibrium thermodynamics explain skeletal muscle insulin resistance due to low mitochondrial content? Lancet Diabetes Endocrinol 2023; 11:149-151. [PMID: 36822742 DOI: 10.1016/s2213-8587(23)00032-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/18/2023] [Accepted: 01/23/2023] [Indexed: 02/24/2023]
Affiliation(s)
- Lawrence J Mandarino
- Division of Endocrinology, Department of Medicine, and Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona College of Medicine and University of Arizona Health Sciences, Tucson, AZ 85724, USA.
| | - Wayne T Willis
- Division of Endocrinology, Department of Medicine, and Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona College of Medicine and University of Arizona Health Sciences, Tucson, AZ 85724, USA
| |
Collapse
|
6
|
Corenblum MJ, McRobbie-Johnson A, Carruth E, Bernard K, Luo M, Mandarino LJ, Peterson S, Billheimer D, Maley T, Eggers ED, Madhavan L. Parallel Neurodegenerative Phenotypes in Sporadic Parkinson's Disease Fibroblasts and Midbrain Dopamine Neurons. bioRxiv 2023:2023.02.10.527867. [PMID: 36798207 PMCID: PMC9934693 DOI: 10.1101/2023.02.10.527867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they also differed in their nature and scale. Furthermore, statistical analysis revealed novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
Collapse
|
7
|
Barakati N, Bustos RZ, Coletta DK, Langlais PR, Kohler LN, Luo M, Funk JL, Willis WT, Mandarino LJ. Fuel Selection in Skeletal Muscle Exercising at Low Intensity; Reliance on Carbohydrate in Very Sedentary Individuals. Metab Syndr Relat Disord 2023; 21:16-24. [PMID: 36318809 PMCID: PMC9969886 DOI: 10.1089/met.2022.0062] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
Background: Resting skeletal muscle in insulin resistance prefers to oxidize carbohydrate rather than lipid, exhibiting metabolic inflexibility. Although this is established in resting muscle, complexities involved in directly measuring fuel oxidation using indirect calorimetry across a muscle bed have limited studies of this phenomenon in working skeletal muscle. During mild exercise and at rest, whole-body indirect calorimetry imperfectly estimates muscle fuel oxidation. We provide evidence that a method termed "ΔRER" can reasonably estimate fuel oxidation in skeletal muscle activated by exercise. Methods: Completely sedentary volunteers (n = 20, age 31 ± 2 years, V̇O2peak 24.4 ± 1.5 mL O2 per min/kg) underwent glucose clamps to determine insulin sensitivity and graded exercise consisting of three periods of mild steady-state cycle ergometry (15, 30, 45 watts, or 10%, 20%, and 30% of maximum power) with measurements of whole-body gas exchange. ΔRER, the RER in working muscle, was calculated as (V̇CO2exercise -V̇CO2rest)/(V̇O2exercise - V̇O2rest), from which the fraction of fuel accounted for by lipid was estimated. Results: Lactate levels were low and stable during steady-state exercise. Muscle biopsies were used to estimate mitochondrial content. The rise of V̇O2 at onset of exercise followed a monoexponential function, with a time constant of 51 ± 7 sec, typical of skeletal muscle; the average O2 cost of work was about 12 mL O2/watt/min, representing a mechanical efficiency of about 24%. At work rates of 30 or 45 watts, active muscle relied predominantly on carbohydrate, independent of insulin sensitivity within this group of very sedentary volunteers. Conclusions: The fraction of muscle fuel oxidation from fat was predicted by power output (P < 0.001) and citrate synthase activity (P < 0.05), indicating that low mitochondrial content may be the main driver of fuel choice in sedentary people, independent of insulin sensitivity.
Collapse
Affiliation(s)
- Neusha Barakati
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, Arizona, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Health Sciences, Tucson, Arizona, USA
| | - Rocio Zapata Bustos
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, Arizona, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Health Sciences, Tucson, Arizona, USA
| | - Dawn K. Coletta
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, Arizona, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Health Sciences, Tucson, Arizona, USA
- Department of Physiology, The University of Arizona, Tucson, Arizona, USA
| | - Paul R. Langlais
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, Arizona, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Health Sciences, Tucson, Arizona, USA
| | - Lindsay N. Kohler
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Health Sciences, Tucson, Arizona, USA
- Department of Health Promotion Sciences, Epidemiology and Biostatistics and The University of Arizona, Tucson, Arizona, USA
- Department of Mel and Enid Zuckerman College of Public Health, The University of Arizona, Tucson, Arizona, USA
| | - Moulun Luo
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, Arizona, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Health Sciences, Tucson, Arizona, USA
| | - Janet L. Funk
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, Arizona, USA
| | - Wayne T. Willis
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, Arizona, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Health Sciences, Tucson, Arizona, USA
| | - Lawrence J. Mandarino
- Division of Endocrinology, Department of Medicine, The University of Arizona, Tucson, Arizona, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Health Sciences, Tucson, Arizona, USA
| |
Collapse
|
8
|
Chang PFM, Acevedo D, Mandarino LJ, Reyna SM. Triterpenoid CDDO-EA inhibits lipopolysaccharide-induced inflammatory responses in skeletal muscle cells through suppression of NF-κB. Exp Biol Med (Maywood) 2023; 248:175-185. [PMID: 36661241 PMCID: PMC10041051 DOI: 10.1177/15353702221139188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Accepted: 10/04/2022] [Indexed: 01/21/2023] Open
Abstract
Chronic inflammation is a major contributor to the development of obesity-induced insulin resistance, which then can lead to the development of type 2 diabetes (T2D). Skeletal muscle plays a pivotal role in insulin-stimulated whole-body glucose disposal. Therefore, dysregulation of glucose metabolism by inflammation in skeletal muscle can adversely affect skeletal muscle insulin sensitivity and contribute to the pathogenesis of T2D. The mechanism underlying insulin resistance is not well known; however, macrophages are important initiators in the development of the chronic inflammatory state leading to insulin resistance. Skeletal muscle consists of resident macrophages which can be activated by lipopolysaccharide (LPS). These activated macrophages affect myocytes via a paracrine action of pro-inflammatory mediators resulting in secretion of myokines that contribute to inflammation and ultimately skeletal muscle insulin resistance. Therefore, knowing that synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acids (CDDOs) can attenuate macrophage pro-inflammatory responses in chronic disorders, such as cancer and obesity, and that macrophage pro-inflammatory responses can modulate skeletal muscle inflammation, we first examined whether CDDO-ethyl amide (CDDO-EA) inhibited chemokine and cytokine production in macrophages since this had not been reported for CDDO-EA. CDDO-EA blocked LPS-induced tumor necrosis factor-alpha (TNF-α), monocyte chemotactic protein-1 (MCP-1), interleukine-1beta (IL-1β), and interleukine-6 (IL-6) production in RAW 264.7 mouse and THP-1 human macrophages. Although many studies show that CDDOs have anti-inflammatory properties in several tissues and cells, little is known about the anti-inflammatory effects of CDDOs on skeletal muscle. We hypothesized that CDDO-EA protects skeletal muscle from LPS-induced inflammation by blocking nuclear factor kappa B (NF-κB) signaling. Our studies demonstrate that CDDO-EA prevented LPS-induced TNF-α and MCP-1 gene expression by inhibiting the NF-κB signaling pathway in L6-GLUT4myc rat myotubes. Our findings suggest that CDDO-EA suppresses LPS-induced inflammation in macrophages and myocytes and that CDDO-EA is a promising compound as a therapeutic agent for protecting skeletal muscle from inflammation.
Collapse
Affiliation(s)
- Phoebe Fang-Mei Chang
- Department of Endodontics, School of Dentistry, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
| | - Daniel Acevedo
- Department of Human Genetics, School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA
| | - Lawrence J Mandarino
- Center for Disparities in Diabetes, Obesity and Metabolism, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, The University of Arizona, Tucson, AZ 85724, USA
| | - Sara M Reyna
- Department of Human Genetics, School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA
| |
Collapse
|
9
|
Standage-Beier CS, Ziller SG, Bakhshi B, Parra OD, Mandarino LJ, Kohler LN, Coletta DK. Tools to Measure Health Literacy among Adult Hispanic Populations with Type 2 Diabetes Mellitus: A Review of the Literature. Int J Environ Res Public Health 2022; 19:12551. [PMID: 36231846 PMCID: PMC9566768 DOI: 10.3390/ijerph191912551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/15/2022] [Revised: 09/27/2022] [Accepted: 09/28/2022] [Indexed: 06/16/2023]
Abstract
Health literacy (HL) is associated with short- and long-term health outcomes, and this is particularly relevant in Hispanics, who are disproportionally affected by lower HL. Hispanics have become the largest minority population in the United States. Also, Hispanics experience higher burdens of chronic diseases such as type 2 diabetes mellitus (T2DM) than non-Hispanic whites. Thus, effectively choosing culturally appropriate validated instruments that measure a marker found in health assessments should be a serious consideration. Using a systemized approach, we identified and reviewed 33 publications and found eight different HL and numeracy (separate or combined) instruments. We assessed the study designs and instrument structures to determine how HL was measured across these studies. We categorized the results into direct and indirect measurements of HL. The Test of Functional Health Literacy in Adults (TOFHLA) family of HL instruments was favored for direct measures of HL, while the Brief Health Literacy Screen (BHLS) instrument was favored for indirect measures. Despite identified trends in instruments used, more comprehensive measurement tools have been developed but not validated in Hispanic populations. In conclusion, further validation of more comprehensive HL instruments in adult Hispanic populations with T2DM could better assess HL levels and improve health promotion efforts.
Collapse
Affiliation(s)
| | - Shelby G. Ziller
- Department of Epidemiology and Biostatistics, University of Arizona, Tucson, AZ 85721, USA
| | - Bahar Bakhshi
- School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ 85721, USA
| | - Oscar D. Parra
- UA Center for Disparities in Diabetes, Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA
| | - Lawrence J. Mandarino
- UA Center for Disparities in Diabetes, Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA
| | - Lindsay N. Kohler
- UA Center for Disparities in Diabetes, Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA
| | - Dawn K. Coletta
- UA Center for Disparities in Diabetes, Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA
- Department of Physiology, University of Arizona, Tucson, AZ 85724, USA
| |
Collapse
|
10
|
Parra OD, Kohler LN, Landes L, Soto AA, Garcia D, Mullins J, Molina P, Pereira E, Spegman DJ, Soltani L, Mandarino LJ. Biobanking in Latinos: current status, principles for conduct, and contribution of a new biobank, El Banco por Salud, designed to improve the health of Latino patients of Mexican ancestry with type 2 diabetes. BMJ Open Diabetes Res Care 2022; 10:e002709. [PMID: 35504695 PMCID: PMC9066498 DOI: 10.1136/bmjdrc-2021-002709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Accepted: 03/19/2022] [Indexed: 11/03/2022] Open
Abstract
Underserved Latino communities experience a greater burden of type 2 diabetes mellitus (T2DM) than the general population. Predictors of glycemic control are likely to include both biological/genetic and social determinants of health (SDOH). A variety of approaches have been used with cohorts of Latino patients to study aspects of this health disparity, and those are reviewed briefly here. Such projects range from cohorts that are studies for a primary purpose, for example, to discover genetic variation associated with T2DM or to examine a particular aspect of SDOH that might be involved. Other studies have been conducted more as infrastructure that is broadly based in order to provide a resource that can be used by many investigators to address a variety of questions. From our experience and those of others, we propose a set of principles to ensure that needs of the community are identified and taken into account during the conduct of these studies. As an example of the implementation of these principles, we also describe a new biobank El Banco por Salud (El Banco), which was designed to improve access to studies designed to improve glycemic control and health in Latinos in partnership with Federally Qualified Health Centers in Arizona.
Collapse
Affiliation(s)
- Oscar D Parra
- Department of Medicine, University of Arizona Medical Center-University Campus, Tucson, Arizona, USA
| | - Lindsay N Kohler
- Health Promotion Sciences, The University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, Arizona, USA
- Mel and Edith Zuckerman College of Public Health, University of Arizona Medical Center-University Campus, Tucson, Arizona, USA
| | - Lori Landes
- El Rio Community Health Centers, Tucson, Arizona, USA
- Department of Family Medicine and Population Health, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA
| | - Alexis A Soto
- Department of Medicine, University of Arizona Medical Center-University Campus, Tucson, Arizona, USA
| | - Diana Garcia
- Department of Medicine, University of Arizona Medical Center-University Campus, Tucson, Arizona, USA
| | | | - Patty Molina
- Mariposa Community Health Centers, Nogales, Arizona, USA
| | - Eladio Pereira
- Mariposa Community Health Centers, Nogales, Arizona, USA
| | | | - Lisa Soltani
- El Rio Community Health Centers, Tucson, Arizona, USA
| | - Lawrence J Mandarino
- Department of Medicine, University of Arizona Medical Center-University Campus, Tucson, Arizona, USA
| |
Collapse
|
11
|
Standage-Beier CS, Bakhshi B, Parra OD, Soltani L, Spegman DJ, Molina P, Pereira E, Landes L, Mandarino LJ, Kohler LN. Fruit, Vegetable, and Physical Activity Guideline Adherence and Metabolic Syndrome in El Banco por Salud. Nutrients 2022; 14:nu14091767. [PMID: 35565734 PMCID: PMC9101454 DOI: 10.3390/nu14091767] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Revised: 04/15/2022] [Accepted: 04/21/2022] [Indexed: 02/01/2023] Open
Abstract
Adherence to dietary and physical activity recommendations has been associated with reductions in morbidity and mortality. The association between baseline adherence to fruit, vegetable, and physical activity guidelines and metabolic syndrome (MetS) in El Banco por Salud (El Banco) was examined. El Banco is a wellness biobank for Latino individuals affiliated with partnered Federally Qualified Health Centers in southern Arizona. Study participants (n = 972) were 65% female, 62.3% foreign-born, 56.3% obese, 29.2% food insecure, and with an average age of 51.3 years. Adherence scores were developed using baseline questionnaires for fruits and vegetable consumption and self-reported physical activity. Adherence was low in those fully meeting guidelines for fruit, vegetable, and physical activity at 14.6%, 37.5%, and 23.5%, respectively. Roughly 65% (n = 630) had ≥3 cardiometabolic risk factors. Large waist circumference was the most prevalent risk factor at 77.9%. Adherence to physical activity recommendations differed by MetS status with 32.8% without MetS reporting ≥150 min of physical activity per week compared to 18.5% in those with MetS (p < 0.001). There were no significant associations with adherence to any guidelines and MetS in the fully adjusted model. Overall, in this sample guideline adherence was low and the cardiometabolic risk factors prevalence was high.
Collapse
Affiliation(s)
- Carrie S. Standage-Beier
- School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ 85721, USA; (C.S.S.-B.); (B.B.)
| | - Bahar Bakhshi
- School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ 85721, USA; (C.S.S.-B.); (B.B.)
| | - Oscar D. Parra
- Center for Disparities in Diabetes, Obesity and Metabolism, University of Arizona, Tucson, AZ 85721, USA; (O.D.P.); (L.J.M.)
| | - Lisa Soltani
- El Rio Community Health Centers, Tucson, AZ 85712, USA; (L.S.); (D.J.S.)
| | - Douglas J. Spegman
- El Rio Community Health Centers, Tucson, AZ 85712, USA; (L.S.); (D.J.S.)
| | - Patty Molina
- Mariposa Community Health Centers, Tucson, AZ 85621, USA; (P.M.); (E.P.)
| | - Eladio Pereira
- Mariposa Community Health Centers, Tucson, AZ 85621, USA; (P.M.); (E.P.)
| | - Lori Landes
- Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, VA 23284, USA;
| | - Lawrence J. Mandarino
- Center for Disparities in Diabetes, Obesity and Metabolism, University of Arizona, Tucson, AZ 85721, USA; (O.D.P.); (L.J.M.)
| | - Lindsay N. Kohler
- Center for Disparities in Diabetes, Obesity and Metabolism, University of Arizona, Tucson, AZ 85721, USA; (O.D.P.); (L.J.M.)
- Department of Epidemiology and Biostatistics, University of Arizona, Tucson, AZ 85721, USA
- Department of Health Promotion Sciences, University of Arizona, Tucson, AZ 85721, USA
- Correspondence:
| |
Collapse
|
12
|
Garcia LA, Zapata-Bustos R, Day SE, Campos B, Hamzaoui Y, Wu L, Leon AD, Krentzel J, Coletta RL, De Filippis E, Roust LR, Mandarino LJ, Coletta DK. Can Exercise Training Alter Human Skeletal Muscle DNA Methylation? Metabolites 2022; 12:metabo12030222. [PMID: 35323665 PMCID: PMC8953782 DOI: 10.3390/metabo12030222] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Revised: 02/28/2022] [Accepted: 02/28/2022] [Indexed: 12/26/2022] Open
Abstract
Skeletal muscle is highly plastic and dynamically regulated by the body’s physical demands. This study aimed to determine the plasticity of skeletal muscle DNA methylation in response to 8 weeks of supervised exercise training in volunteers with a range of insulin sensitivities. We studied 13 sedentary participants and performed euglycemic hyperinsulinemic clamps with basal vastus lateralis muscle biopsies and peak aerobic activity (VO2 peak) tests before and after training. We extracted DNA from the muscle biopsies and performed global methylation using Illumina’s Methylation EPIC 850K BeadChip. Training significantly increased peak aerobic capacity and insulin-stimulated glucose disposal. Fasting serum insulin and insulin levels during the steady state of the clamp were significantly lower post-training. Insulin clearance rates during the clamp increased following the training. We identified 13 increased and 90 decreased differentially methylated cytosines (DMCs) in response to 8 weeks of training. Of the 13 increased DMCs, 2 were within the following genes, FSTL3, and RP11-624M8.1. Of the 90 decreased DMCs, 9 were within the genes CNGA1, FCGR2A, KIF21A, MEIS1, NT5DC1, OR4D1, PRPF4B, SLC26A7, and ZNF280C. Moreover, pathway analysis showed an enrichment in metabolic and actin-cytoskeleton pathways for the decreased DMCs, and for the increased DMCs, an enrichment in signal-dependent regulation of myogenesis, NOTCH2 activation and transmission, and SMAD2/3: SMAD4 transcriptional activity pathways. Our findings showed that 8 weeks of exercise training alters skeletal muscle DNA methylation of specific genes and pathways in people with varying degrees of insulin sensitivity.
Collapse
Affiliation(s)
- Luis A. Garcia
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (R.Z.-B.); (B.C.); (A.D.L.); (J.K.); (L.J.M.)
- Center for Disparities in Diabetes Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA;
| | - Rocio Zapata-Bustos
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (R.Z.-B.); (B.C.); (A.D.L.); (J.K.); (L.J.M.)
- Center for Disparities in Diabetes Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA;
| | - Samantha E. Day
- Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85004, USA;
| | - Baltazar Campos
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (R.Z.-B.); (B.C.); (A.D.L.); (J.K.); (L.J.M.)
- Center for Disparities in Diabetes Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA;
| | - Yassin Hamzaoui
- Department of Physiology, University of Arizona, Tucson, AZ 85724, USA; (Y.H.); (L.W.)
| | - Linda Wu
- Department of Physiology, University of Arizona, Tucson, AZ 85724, USA; (Y.H.); (L.W.)
| | - Alma D. Leon
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (R.Z.-B.); (B.C.); (A.D.L.); (J.K.); (L.J.M.)
- Center for Disparities in Diabetes Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA;
| | - Judith Krentzel
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (R.Z.-B.); (B.C.); (A.D.L.); (J.K.); (L.J.M.)
- Center for Disparities in Diabetes Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA;
| | - Richard L. Coletta
- Center for Disparities in Diabetes Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA;
| | - Eleanna De Filippis
- Department of Endocrinology, Metabolism and Diabetes, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA; (E.D.F.); (L.R.R.)
| | - Lori R. Roust
- Department of Endocrinology, Metabolism and Diabetes, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA; (E.D.F.); (L.R.R.)
| | - Lawrence J. Mandarino
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (R.Z.-B.); (B.C.); (A.D.L.); (J.K.); (L.J.M.)
- Center for Disparities in Diabetes Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA;
| | - Dawn K. Coletta
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA; (L.A.G.); (R.Z.-B.); (B.C.); (A.D.L.); (J.K.); (L.J.M.)
- Center for Disparities in Diabetes Obesity and Metabolism, University of Arizona, Tucson, AZ 85724, USA;
- Department of Physiology, University of Arizona, Tucson, AZ 85724, USA; (Y.H.); (L.W.)
- Correspondence: ; Tel.: +1-(520)-626-9316
| |
Collapse
|
13
|
McGraw MB, Kohler LN, Shaibi GQ, Mandarino LJ, Coletta DK. A performance review of novel adiposity indices for assessing insulin resistance in a pediatric Latino population. Front Pediatr 2022; 10:1020901. [PMID: 36275055 PMCID: PMC9582658 DOI: 10.3389/fped.2022.1020901] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/16/2022] [Accepted: 09/21/2022] [Indexed: 11/14/2022] Open
Abstract
INTRODUCTION Body mass index (BMI) percentile or BMI adjusted for age and sex is the most common anthropometric index to monitor and assess obesity in children. However, the ability of BMI to accurately predict insulin resistance (IR) in youth is debated. Determining the best method to noninvasively measure IR in the pediatric population is especially important due to the growing prevalence of type 2 diabetes mellitus (T2DM), which is more likely to develop in people with IR. Therefore, this study analyzed the performance of BMI against newer anthropometric indices in assessing IR in a pediatric Latino identifying sample. METHODS We studied 127 pediatric Latino participants from the Arizona Insulin Resistance (AIR) registry and performed linear regression analyses between various measures of IR and adiposity indices, including body mass index (BMI), triponderal mass index (TMI), body adiposity index (BAI), pediatric body adiposity index (pBAI), a body shape index (ABSI), abdominal volume index (AVI), waist to height ratio (WtHR) and waist to hip ratio (WHR). Log transformations of each index adjusted for age and sex and IR were used for the linear regressions. Additionally, we generated receiver operating characteristics (ROC) from logistic regressions between HOMA-IR and HOMA2IR against the same indices. RESULTS Using the homeostatic assessment of insulin resistance (HOMA-IR), HOMA2IR, the quantitative insulin-sensitivity check index (QUICKI), fasting serum insulin, and FPG/FSI to measure IR, we showed that BMI adjusted for age and sex performs similarly to many of the newer indices in our sample. The correlation coefficients for pBAI [R2: 0.27, 95% confidence interval: 0.88-1.81, p < 0.001] and BMI [R2: 0.27, 95% confidence interval: 0.92-1.92, p < 0.001] were the highest for HOMA-IR. Similarly, pBAI [R2: 0.29, 95% confidence interval: 0.88-1.72, p < 0.001] and BMI [R2: 0.29, 95% confidence interval: 0.93-1.83, p < 0.001] were the highest for HOMA2IR. A similar trend was observed with QUICKI, FSI, and FPG/FSI. ABSI had the lowest R 2 value for all measures of IR. Area under the curve (AUC) values for the receiver operating characteristics (ROC) for HOMA-IR and HOMA2IR support these conclusions. CONCLUSIONS BMI adjusted for age and sex, despite its usage and simplicity, still stacks up well against newer indices in our Latino sample. Testing these indices across larger samples is necessary to generalize these findings and translate performance to adults.
Collapse
Affiliation(s)
- Mac B McGraw
- Department of Physiology, The University of Arizona College of Medicine, Tucson, AZ, United States
| | - Lindsay N Kohler
- Center for Disparities in Diabetes, Obesity and Metabolism, The University of Arizona, Tucson, AZ, United States.,Exos, Phoenix, AZ, United States
| | - Gabriel Q Shaibi
- Center for Health Promotion and Disease Prevention, Arizona State University, Phoenix, AZ, United States
| | - Lawrence J Mandarino
- Center for Disparities in Diabetes, Obesity and Metabolism, The University of Arizona, Tucson, AZ, United States.,Department of Medicine, Division of Endocrinology, The University of Arizona College of Medicine, Tucson, AZ, United States
| | - Dawn K Coletta
- Department of Physiology, The University of Arizona College of Medicine, Tucson, AZ, United States.,Center for Disparities in Diabetes, Obesity and Metabolism, The University of Arizona, Tucson, AZ, United States.,Department of Medicine, Division of Endocrinology, The University of Arizona College of Medicine, Tucson, AZ, United States
| |
Collapse
|
14
|
Coletta DK, Hlusko LJ, Scott GR, Garcia LA, Vachon CM, Norman AD, Funk JL, Shaibi GQ, Hernandez V, De Filippis E, Mandarino LJ. Association of EDARV370A with breast density and metabolic syndrome in Latinos. PLoS One 2021; 16:e0258212. [PMID: 34618839 PMCID: PMC8496850 DOI: 10.1371/journal.pone.0258212] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2021] [Accepted: 09/21/2021] [Indexed: 12/02/2022] Open
Abstract
The ectodysplasin receptor (EDAR) is a tumor necrosis factor receptor (TNF) superfamily member. A substitution in an exon of EDAR at position 370 (EDARV370A) creates a gain of function mutant present at high frequencies in Asian and Indigenous American populations but absent in others. Its frequency is intermediate in populations of Mexican ancestry. EDAR regulates the development of ectodermal tissues, including mammary ducts. Obesity and type 2 diabetes mellitus are prevalent in people with Indigenous and Latino ancestry. Latino patients also have altered prevalence and presentation of breast cancer. It is unknown whether EDARV370A might connect these phenomena. The goals of this study were to determine 1) whether EDARV370A is associated with metabolic phenotypes and 2) if there is altered breast anatomy in women carrying EDARV370A. Participants were from two Latino cohorts, the Arizona Insulin Resistance (AIR) registry and Sangre por Salud (SPS) biobank. The frequency of EDARV370A was 47% in the Latino cohorts. In the AIR registry, carriers of EDARV370A (GG homozygous) had significantly (p < 0.05) higher plasma triglycerides, VLDL, ALT, 2-hour post-challenge glucose, and a higher prevalence of prediabetes/diabetes. In a subset of the AIR registry, serum levels of ectodysplasin A2 (EDA-A2) also were associated with HbA1c and prediabetes (p < 0.05). For the SPS biobank, participants that were carriers of EDARV370A had lower breast density and higher HbA1c (both p < 0.05). The significant associations with measures of glycemia remained when the cohorts were combined. We conclude that EDARV370A is associated with characteristics of the metabolic syndrome and breast density in Latinos.
Collapse
Affiliation(s)
- Dawn K. Coletta
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, Arizona, United States of America
- Department of Physiology, University of Arizona, Tucson, Arizona, United States of America
- Center for Disparities in Diabetes Obesity, and Metabolism, University of Arizona, Tucson, Arizona, United States of America
- * E-mail:
| | - Leslea J. Hlusko
- Department of Integrative Biology, University of California, Berkeley, California, United States of America
- Centro Nacional de Investigación sobre la Evolución Humana, Burgos, Spain
| | - G. Richard Scott
- Department of Anthropology, University of Nevada, Reno, Nevada, United States of America
| | - Luis A. Garcia
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, Arizona, United States of America
- Center for Disparities in Diabetes Obesity, and Metabolism, University of Arizona, Tucson, Arizona, United States of America
| | - Celine M. Vachon
- Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, United States of America
| | - Aaron D. Norman
- Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, United States of America
| | - Janet L. Funk
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, Arizona, United States of America
- Department of Nutritional Sciences, University of Arizona, Tucson, Arizona, United States of America
| | - Gabriel Q. Shaibi
- Center for Health Promotion and Disease Prevention, Arizona State University, Phoenix, Arizona, United States of America
| | | | - Eleanna De Filippis
- Department of Endocrinology, Metabolism and Diabetes, Mayo Clinic Arizona, Scottsdale, Arizona, United States of America
| | - Lawrence J. Mandarino
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, Arizona, United States of America
- Center for Disparities in Diabetes Obesity, and Metabolism, University of Arizona, Tucson, Arizona, United States of America
| |
Collapse
|
15
|
Finlayson J, Barakati N, Langlais PR, Funk J, Zapata Bustos R, Coletta DK, Luo M, Willis WT, Mandarino LJ. Site-specific acetylation of adenine nucleotide translocase 1 at lysine 23 in human muscle. Anal Biochem 2021; 630:114319. [PMID: 34332952 DOI: 10.1016/j.ab.2021.114319] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Revised: 07/14/2021] [Accepted: 07/28/2021] [Indexed: 12/01/2022]
Abstract
Evidence suggests acetylation of human adenine nucleotide translocase 1 (ANT1) at lysine 23 (Lys23) reduces binding of ADP. Lys23 contributes to the positive charge that facilitates this interaction. This study was undertaken to characterize ANT1 abundance and acetylation by a novel method using small amounts of human skeletal muscle biopsies. Lysates of whole muscle or mitochondria from the same tissue were prepared from needle biopsies of vastus lateralis muscle of healthy volunteers. Lysed proteins were resolved on gels, the section containing ANT1 (surrounding 30 Kd) was excised, digested with trypsin, spiked with labeled unacetylated and acetylated synthetic standard peptides and analyzed by mass spectrometry. Natural logarithm transformation of data linearized ion intensities over a 10-fold range of peptide mass. Coefficients of variation ranged from 7 to 30% for ANT1 abundance and Lys23 acetylation. In three volunteers, ANT1 content was 8.36 ± 0.33 nmol/g wet weight muscle and 0.64 ± 0.05 nmol/mg mitochondria, so mitochondrial content was 13.3 ± 2.4 mg mitochondria per gram muscle. Acetylation of Lys23 averaged 14.3 ± 4.2% and 4.87 ± 1.84% in whole muscle and mitochondria, respectively. This assay makes it possible to assess effects of acetylation on the function of ANT1 in human muscle.
Collapse
Affiliation(s)
- Jean Finlayson
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Science, Tucson, AZ, USA
| | - Neusha Barakati
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Science, Tucson, AZ, USA
| | - Paul R Langlais
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Science, Tucson, AZ, USA
| | - Janet Funk
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA
| | - Rocio Zapata Bustos
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Science, Tucson, AZ, USA
| | - Dawn K Coletta
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Science, Tucson, AZ, USA; Department of Physiology, University of Arizona, Tucson, AZ, USA
| | - Moulun Luo
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Science, Tucson, AZ, USA
| | - Wayne T Willis
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Science, Tucson, AZ, USA
| | - Lawrence J Mandarino
- Division of Endocrinology, Department of Medicine, University of Arizona, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Science, Tucson, AZ, USA.
| |
Collapse
|
16
|
Luo M, Ma W, Zapata-Bustos R, Willis WT, Mandarino LJ. Deletion of Von Willebrand A Domain Containing Protein (VWA8) raises activity of mitochondrial electron transport chain complexes in hepatocytes. Biochem Biophys Rep 2021; 26:100928. [PMID: 33665377 PMCID: PMC7900673 DOI: 10.1016/j.bbrep.2021.100928] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Revised: 01/19/2021] [Accepted: 01/19/2021] [Indexed: 11/27/2022] Open
Abstract
VWA8 (Von Willebrand A Domain Containing Protein 8) is a AAA+ ATPase that is localized to the mitochondrial matrix and is widely expressed in highly energetic tissues. Originally found to be higher in abundance in livers of mice fed a high fat diet, deletion of the VWA8 gene in differentiated mouse AML12 hepatocytes unexpectedly produced a phenotype of higher mitochondrial and nonmitochondrial oxidative metabolism, higher ROS (reactive oxygen species) production mainly from NADPH oxidases, and increased HNF4a expression. The purposes of this study were first, to determine whether higher mitochondrial oxidative capacity in VWA8 null hepatocytes is the product of higher capacity in all aspects of the electron transport chain and oxidative phosphorylation, and second, the density of cristae in mitochondria and mitochondrial content was measured to determine if higher mitochondrial oxidative capacity is accompanied by greater cristae area and mitochondrial abundance. Electron transport chain complexes I, II, III, and IV activities all were higher in hepatocytes in which the VWA8 gene had been deleted using CRISPR/Cas9. A comparison of abundance of proteins in electron transport chain complexes I, III and ATP synthase previously determined using an unbiased proteomics approach in hepatocytes in which VWA8 had been deleted showed agreement with the activity assays. Mitochondrial cristae, the site where electron transport chain complexes are located, were quantified using electron microscopy and stereology. Cristae density, per mitochondrial area, was almost two-fold higher in the VWA8 null cells (P < 0.01), and mitochondrial area was two-fold higher in the VWA8 null cells (P < 0.05). The results of this study allow us to conclude that despite sustained, higher ROS production in VWA8 null cells, a global mitochondrial compensatory response was maintained, resulting in overall higher mitochondrial oxidative capacity.
Collapse
Key Words
- ADP, adenine dinucleotide phosphate
- ANT, adenine nucleotide translocase
- ATP, adenine trinucleotide phosphate
- ETC, electron transport chain
- Electron transport chain
- HNF4, hepatocyte nuclear factor 4
- Hepatocytes
- Mitochondria
- NADPH, nicotinamide adenine dinucleotide phosphate
- OCR, oxygen consumption rate
- PFO, perfringolysin
- ROS, reactive oxygen species
- TMHQ, Tetramethylhydroquinone
- TMPD, N,N,N′,N'-Tetramethyl-p-phenylenediamine
- VWA8
- VWA8, Von Willebrand Domain-containing Protein 8
Collapse
Affiliation(s)
- Moulun Luo
- Department of Medicine, Division of Endocrinology, USA
| | - Wuqiong Ma
- Department of Medicine, Division of Endocrinology, USA
| | | | - Wayne T. Willis
- Department of Medicine, Division of Endocrinology, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, The University of Arizona, Tucson, AZ, 85724, USA
| | - Lawrence J. Mandarino
- Department of Medicine, Division of Endocrinology, USA
- Center for Disparities in Diabetes, Obesity, and Metabolism, The University of Arizona, Tucson, AZ, 85724, USA
| |
Collapse
|
17
|
Garcia LA, Day SE, Coletta RL, Campos B, Benjamin TR, De Filippis E, Madura JA, Mandarino LJ, Roust LR, Coletta DK. Weight loss after Roux-En-Y gastric bypass surgery reveals skeletal muscle DNA methylation changes. Clin Epigenetics 2021; 13:100. [PMID: 33933146 PMCID: PMC8088644 DOI: 10.1186/s13148-021-01086-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Accepted: 04/21/2021] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND The mechanisms of weight loss and metabolic improvements following bariatric surgery in skeletal muscle are not well known; however, epigenetic modifications are likely to contribute. The aim of our study was to investigate skeletal muscle DNA methylation after weight loss induced by Roux-en-Y gastric bypass (RYGB) surgery. Muscle biopsies were obtained basally from seven insulin-resistant obese (BMI > 40 kg/m2) female subjects (45.1 ± 3.6 years) pre- and 3-month post-surgery with euglycemic hyperinsulinemic clamps to assess insulin sensitivity. Four lean (BMI < 25 kg/m2) females (38.5 ± 5.8 years) served as controls. We performed reduced representation bisulfite sequencing next generation methylation on DNA isolated from the vastus lateralis muscle biopsies. RESULTS Global methylation was significantly higher in the pre- (32.97 ± 0.02%) and post-surgery (33.31 ± 0.02%) compared to the lean (30.46 ± 0.02%), P < 0.05. MethylSig analysis identified 117 differentially methylated cytosines (DMCs) that were significantly altered in the post- versus pre-surgery (Benjamini-Hochberg q < 0.05). In addition, 2978 DMCs were significantly altered in the pre-surgery obese versus the lean controls (Benjamini-Hochberg q < 0.05). For the post-surgery obese versus the lean controls, 2885 DMCs were altered (Benjamini-Hochberg q < 0.05). Seven post-surgery obese DMCs were normalized to levels similar to those observed in lean controls. Of these, 5 were within intergenic regions (chr11.68,968,018, chr16.73,100,688, chr5.174,115,531, chr5.1,831,958 and chr9.98,547,011) and the remaining two DMCs chr17.45,330,989 and chr14.105,353,824 were within in the integrin beta 3 (ITGB3) promoter and KIAA0284 exon, respectively. ITGB3 methylation was significantly decreased in the post-surgery (0.5 ± 0.5%) and lean controls (0 ± 0%) versus pre-surgery (13.6 ± 2.7%, P < 0.05). This decreased methylation post-surgery was associated with an increase in ITGB3 gene expression (fold change + 1.52, P = 0.0087). In addition, we showed that ITGB3 promoter methylation in vitro significantly suppressed transcriptional activity (P < 0.05). Transcription factor binding analysis for ITGB3 chr17.45,330,989 identified three putative transcription factor binding motifs; PAX-5, p53 and AP-2alphaA. CONCLUSIONS These results demonstrate that weight loss after RYGB alters the epigenome through DNA methylation. In particular, this study highlights ITGB3 as a novel gene that may contribute to the metabolic improvements observed post-surgery. Future additional studies are warranted to address the exact mechanism of ITGB3 in skeletal muscle.
Collapse
Affiliation(s)
- Luis A Garcia
- Department of Medicine, Division of Endocrinology, The University of Arizona College of Medicine, 1501 N. Campbell Ave, PO Box 245035, Tucson, AZ, 85724-5035, USA
| | - Samantha E Day
- Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA
| | - Richard L Coletta
- Department of Medicine, Division of Endocrinology, The University of Arizona College of Medicine, 1501 N. Campbell Ave, PO Box 245035, Tucson, AZ, 85724-5035, USA
| | - Baltazar Campos
- Department of Medicine, Division of Endocrinology, The University of Arizona College of Medicine, 1501 N. Campbell Ave, PO Box 245035, Tucson, AZ, 85724-5035, USA
| | - Tonya R Benjamin
- Department of Endocrinology, Metabolism and Diabetes, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | - Eleanna De Filippis
- Department of Endocrinology, Metabolism and Diabetes, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | | | - Lawrence J Mandarino
- Department of Medicine, Division of Endocrinology, The University of Arizona College of Medicine, 1501 N. Campbell Ave, PO Box 245035, Tucson, AZ, 85724-5035, USA
| | - Lori R Roust
- Department of Endocrinology, Metabolism and Diabetes, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | - Dawn K Coletta
- Department of Medicine, Division of Endocrinology, The University of Arizona College of Medicine, 1501 N. Campbell Ave, PO Box 245035, Tucson, AZ, 85724-5035, USA. .,Department of Physiology, The University of Arizona College of Medicine, Tucson, AZ, USA.
| |
Collapse
|
18
|
James J, Zemskova M, Eccles CA, Varghese MV, Niihori M, Barker NK, Luo M, Mandarino LJ, Langlais PR, Rafikova O, Rafikov R. Single Mutation in the NFU1 Gene Metabolically Reprograms Pulmonary Artery Smooth Muscle Cells. Arterioscler Thromb Vasc Biol 2021; 41:734-754. [PMID: 33297749 PMCID: PMC7837686 DOI: 10.1161/atvbaha.120.314655] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2020] [Accepted: 11/30/2020] [Indexed: 02/06/2023]
Abstract
OBJECTIVE NFU1 is a mitochondrial iron-sulfur scaffold protein, involved in iron-sulfur assembly and transfer to complex II and LAS (lipoic acid synthase). Patients with the point mutation NFU1G208C and CRISPR/CAS9 (clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeat-associated 9)-generated rats develop mitochondrial dysfunction leading to pulmonary arterial hypertension. However, the mechanistic understanding of pulmonary vascular proliferation due to a single mutation in NFU1 remains unresolved. Approach and Results: Quantitative proteomics of isolated mitochondria showed the entire phenotypic transformation of NFU1G206C rats with a disturbed mitochondrial proteomic landscape, involving significant changes in the expression of 208 mitochondrial proteins. The NFU1 mutation deranged the expression pattern of electron transport proteins, resulting in a significant decrease in mitochondrial respiration. Reduced reliance on mitochondrial respiration amplified glycolysis in pulmonary artery smooth muscle cell (PASMC) and activated GPD (glycerol-3-phosphate dehydrogenase), linking glycolysis to oxidative phosphorylation and lipid metabolism. Decreased PDH (pyruvate dehydrogenase) activity due to the lipoic acid shortage is compensated by increased fatty acid metabolism and oxidation. PASMC became dependent on extracellular fatty acid sources due to upregulated transporters such as CD36 (cluster of differentiation 36) and CPT (carnitine palmitoyltransferase)-1. Finally, the NFU1 mutation produced a dysregulated antioxidant system in the mitochondria, leading to increased reactive oxygen species levels. PASMC from NFU1 rats showed apoptosis resistance, increased anaplerosis, and attained a highly proliferative phenotype. Attenuation of mitochondrial reactive oxygen species by mitochondrial-targeted antioxidant significantly decreased PASMC proliferation. CONCLUSIONS The alteration in iron-sulfur metabolism completely transforms the proteomic landscape of the mitochondria, leading toward metabolic plasticity and redistribution of energy sources to the acquisition of a proliferative phenotype by the PASMC.
Collapse
MESH Headings
- Animals
- Apoptosis
- Cell Proliferation
- Cells, Cultured
- Cellular Reprogramming
- Energy Metabolism
- Fatty Acids/metabolism
- Female
- Mitochondria, Liver/genetics
- Mitochondria, Liver/metabolism
- Mitochondria, Liver/pathology
- Muscle, Smooth, Vascular/metabolism
- Muscle, Smooth, Vascular/pathology
- Myocytes, Smooth Muscle/metabolism
- Myocytes, Smooth Muscle/pathology
- Phenotype
- Point Mutation
- Proteome
- Pulmonary Artery/metabolism
- Pulmonary Artery/pathology
- Rats, Sprague-Dawley
- Reactive Oxygen Species/metabolism
- Signal Transduction
- Rats
Collapse
Affiliation(s)
- Joel James
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Marina Zemskova
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Cody A. Eccles
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Mathews V. Varghese
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Maki Niihori
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Natalie K. Barker
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Moulun Luo
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Lawrence J. Mandarino
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Paul R. Langlais
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Olga Rafikova
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| | - Ruslan Rafikov
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson
| |
Collapse
|
19
|
Blomquist S, Coletta D, Mandarino LJ, Hallmark B, Yang C, Rich S, Manichaikul AW, Chilton F. Fatty Acid Desaturase Gene‐Induced Omega‐3 Deficiency in Amerindian‐Ancestry Hispanic Populations. FASEB J 2020. [DOI: 10.1096/fasebj.2020.34.s1.06389] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
20
|
Rafikov R, Coletta DK, Mandarino LJ, Rafikova O. Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites. J Clin Med 2020; 9:E217. [PMID: 31947516 PMCID: PMC7019706 DOI: 10.3390/jcm9010217] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2019] [Revised: 01/09/2020] [Accepted: 01/10/2020] [Indexed: 12/13/2022] Open
Abstract
Pulmonary arterial hypertension (PAH) is an incurable, progressive disorder, and the early diagnosis and treatment of PAH are associated with increased survival [...].
Collapse
Affiliation(s)
| | | | | | - Olga Rafikova
- Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA; (R.R.); (D.K.C.); (L.J.M.)
| |
Collapse
|
21
|
Luo M, Ma W, Sand Z, Finlayson J, Wang T, Brinton RD, Willis WT, Mandarino LJ. Von Willebrand factor A domain-containing protein 8 (VWA8) localizes to the matrix side of the inner mitochondrial membrane. Biochem Biophys Res Commun 2020; 521:158-163. [PMID: 31630795 PMCID: PMC6928414 DOI: 10.1016/j.bbrc.2019.10.095] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2019] [Accepted: 10/10/2019] [Indexed: 02/09/2023]
Abstract
VWA8 is a poorly characterized mitochondrial AAA + ATPase protein. The specific submitochondrial localization of VWA8 remains unclear. The purpose of this study was to determine the specific submitochondrial compartment within which VWA8 resides in order to provide more insight into the function of this protein. Bioinformatics analysis showed that VWA8 has a 34 amino acid N-terminal Matrix-Targeting Signal (MTS) that is similar to those in proteins known to localize to the mitochondrial matrix. Experiments in C2C12 mouse myoblasts using confocal microscopy showed that deletion of the VWA8 MTS (vMTS) resulted in cytosolic, rather than mitochondrial, localization of VWA8. Biochemical analysis using differential sub-fractionation of mitochondria isolated from rat liver showed that VWA8 localizes to the matrix side of inner mitochondrial membrane, similar to the inner mitochondrial membrane protein Electron Transfer Flavoprotein-ubiquinone Oxidoreductase (ETFDH). The results of these experiments show that the vMTS is essential for localization to the mitochondrial matrix and that once there, VWA8 localizes to the matrix side of inner mitochondrial membrane.
Collapse
Affiliation(s)
- Moulun Luo
- Division of Endocrinology, Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, Tucson, AZ, USA
| | - Wuqiong Ma
- Division of Endocrinology, Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, Tucson, AZ, USA
| | - Zoe Sand
- Division of Endocrinology, Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, Tucson, AZ, USA
| | - Jean Finlayson
- Division of Endocrinology, Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, Tucson, AZ, USA
| | - Tian Wang
- Center for Innovation in Brain Science, University of Arizona Health Sciences, Tucson, AZ, USA
| | - Roberta Diaz Brinton
- Center for Innovation in Brain Science, University of Arizona Health Sciences, Tucson, AZ, USA
| | - Wayne T Willis
- Division of Endocrinology, Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, Tucson, AZ, USA
| | - Lawrence J Mandarino
- Division of Endocrinology, Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA; Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona Health Sciences, Tucson, AZ, USA.
| |
Collapse
|
22
|
Luo M, Willis WT, Coletta DK, Langlais PR, Mengos A, Ma W, Finlayson J, Wagner GR, Shi CX, Mandarino LJ. Deletion of the Mitochondrial Protein VWA8 Induces Oxidative Stress and an HNF4α Compensatory Response in Hepatocytes. Biochemistry 2019; 58:4983-4996. [PMID: 31702900 DOI: 10.1021/acs.biochem.9b00863] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
von Willebrand A domain-containing protein 8 (VWA8) is a poorly characterized, mitochondrial matrix-targeted protein with an AAA ATPase domain and ATPase activity that increases in livers of mice fed a high-fat diet. This study was undertaken to use CRISPR/Cas9 to delete VWA8 in cultured mouse hepatocytes and gain insight into its function. Unbiased omics techniques and bioinformatics were used to guide subsequent assays, including the assessment of oxidative stress and the determination of bioenergetic capacity. Metabolomics analysis showed VWA8 null cells had higher levels of oxidative stress and protein degradation; assays of hydrogen peroxide production revealed higher levels of production of reactive oxygen species (ROS). Proteomics and transcriptomics analyses showed VWA8 null cells had higher levels of expression of mitochondrial proteins (electron transport-chain Complex I, ATP synthase), peroxisomal proteins, and lipid transport proteins. The pattern of higher protein abundance in the VWA8 null cells could be explained by a higher level of hepatocyte nuclear factor 4 α (HNF4α) expression. Bioenergetic assays showed higher rates of carbohydrate oxidation and mitochondrial and nonmitochondrial lipid oxidation in intact and permeabilized cells. Inhibitor assays localized sites of ROS production to peroxisomes and NOX1/4. The rescue of VWA8 protein restored the wild-type phenotype, and treatment with antioxidants decreased the level of HNF4α expression. Thus, loss of VWA8 produces a mitochondrial defect that may be sensed by NOX4, leading to an increase in the level of ROS that results in a higher level of HNF4α. The compensatory HNF4α response results in a higher oxidative capacity and an even higher level of ROS production. We hypothesize that VWA8 is an AAA ATPase protein that plays a role in mitochondrial protein quality.
Collapse
Affiliation(s)
- Moulun Luo
- Division of Endocrinology, Department of Medicine , University of Arizona College of Medicine , Tucson , Arizona 85724 , United States
| | - Wayne T Willis
- Division of Endocrinology, Department of Medicine , University of Arizona College of Medicine , Tucson , Arizona 85724 , United States
| | - Dawn K Coletta
- Division of Endocrinology, Department of Medicine , University of Arizona College of Medicine , Tucson , Arizona 85724 , United States
| | - Paul R Langlais
- Division of Endocrinology, Department of Medicine , University of Arizona College of Medicine , Tucson , Arizona 85724 , United States
| | - April Mengos
- Mayo Clinic in Arizona , Scottsdale , Arizona 85259 , United States
| | - Wuqiong Ma
- Division of Endocrinology, Department of Medicine , University of Arizona College of Medicine , Tucson , Arizona 85724 , United States
| | - Jean Finlayson
- Division of Endocrinology, Department of Medicine , University of Arizona College of Medicine , Tucson , Arizona 85724 , United States
| | - Gregory R Wagner
- Metabolon, Inc. , Research Triangle Park , North Carolina 27709 , United States
| | - Chang-Xin Shi
- Mayo Clinic in Arizona , Scottsdale , Arizona 85259 , United States
| | - Lawrence J Mandarino
- Division of Endocrinology, Department of Medicine , University of Arizona College of Medicine , Tucson , Arizona 85724 , United States
| |
Collapse
|
23
|
Rafikova O, Williams ER, McBride ML, Zemskova M, Srivastava A, Nair V, Desai AA, Langlais PR, Zemskov E, Simon M, Mandarino LJ, Rafikov R. Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension. Am J Respir Cell Mol Biol 2019; 59:334-345. [PMID: 29652520 DOI: 10.1165/rcmb.2017-0308oc] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Although hemolytic anemia-associated pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) are more common than the prevalence of idiopathic PAH alone, the role of hemolysis in the development of PAH is poorly characterized. We hypothesized that hemolysis independently contributes to PAH pathogenesis via endothelial barrier dysfunction with resulting perivascular edema and inflammation. Plasma samples from patients with and without PAH (both confirmed by right heart catheterization) were used to measure free hemoglobin (Hb) and its correlation with PAH severity. A sugen (50 mg/kg)/hypoxia (3 wk)/normoxia (2 wk) rat model was used to elucidate the role of free Hb/heme pathways in PAH. Human lung microvascular endothelial cells were used to study heme-mediated endothelial barrier effects. Our data indicate that patients with PAH have increased levels of free Hb in plasma that correlate with PAH severity. There is also a significant accumulation of free Hb and depletion of haptoglobin in the rat model. In rats, perivascular edema was observed at early time points concomitant with increased infiltration of inflammatory cells. Heme-induced endothelial permeability in human lung microvascular endothelial cells involved activation of the p38/HSP27 pathway. Indeed, the rat model also exhibited increased activation of p38/HSP27 during the initial phase of PH. Surprisingly, despite the increased levels of hemolysis and heme-mediated signaling, there was no heme oxygenase-1 activation. This can be explained by observed destabilization of HIF-1a during the first 2 weeks of PH regardless of hypoxic conditions. Our data suggest that hemolysis may play a significant role in PAH pathobiology.
Collapse
Affiliation(s)
- Olga Rafikova
- 1 Department of Medicine, Division of Endocrinology, and
| | | | | | | | | | - Vineet Nair
- 2 Division of Cardiology, Sarver Heart Center, Department of Medicine, University of Arizona, Tucson, Arizona; and
| | - Ankit A Desai
- 2 Division of Cardiology, Sarver Heart Center, Department of Medicine, University of Arizona, Tucson, Arizona; and
| | | | - Evgeny Zemskov
- 3 Department of Medicine, Division of Translational and Regenerative Medicine, University of Arizona College of Medicine, Tucson, Arizona
| | - Marc Simon
- 4 Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
| | | | - Ruslan Rafikov
- 1 Department of Medicine, Division of Endocrinology, and
| |
Collapse
|
24
|
Jacobs ET, Lance P, Mandarino LJ, Ellis NA, Chow HHS, Foote J, Martinez JA, Hsu CHP, Batai K, Saboda K, Thompson PA. Selenium supplementation and insulin resistance in a randomized, clinical trial. BMJ Open Diabetes Res Care 2019; 7:e000613. [PMID: 30899530 PMCID: PMC6398811 DOI: 10.1136/bmjdrc-2018-000613] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/28/2018] [Revised: 12/13/2018] [Accepted: 12/22/2018] [Indexed: 11/04/2022] Open
Abstract
OBJECTIVE While controversial, observational and randomized clinical trial data implicate the micronutrient selenium (Se) in the development of type 2 diabetes (T2D). The aim of this study was to test the hypothesis that Se supplementation adversely affects pancreatic β-cell function and insulin sensitivity. RESEARCH DESIGN AND METHODS In a subset of 400 individuals participating in a randomized, placebo-controlled trial of Se at 200 µg/day for colorectal adenomatous polyps, fasting plasma glucose and insulin were measured before randomization and within 6 months of completing intervention. Change in the homeostasis model assessment-β cell function (HOMA2-%β) and insulin sensitivity (HOMA2-%S) were compared between arms. A subgroup of 175 (79 Se and 96 placebo) participants underwent a modified oral glucose tolerance test (mOGTT) at the end of intervention and change in glucose values was assessed. RESULTS No statistically significant differences were observed for changes in HOMA2-%β or HOMA2-%S between those who received Se compared with placebo. After a mean of 2.9 years on study, mean HOMA2-%β values were 3.1±24.0 and 3.1±29.8 for the Se and placebo groups, respectively (p=0.99). For HOMA2-%S, the values were -0.5±223.2 and 80.9±1530.9 for the Se and placebo groups, respectively (p=1.00). Stratification by sex or age did not reveal any statistically significant effects on insulin sensitivity by treatment group. For mOGTT, mean baseline fasting blood glucose concentrations were significantly higher among participants in the placebo group compared with the Se group (96.6±14.6 and 92.3±12.0, respectively; p=0.04), a trend which remained through the 20 min assessment. CONCLUSIONS These findings do not support a significant adverse effect of daily Se supplementation with 200 µg/day of selenized yeast on β-cell function or insulin sensitivity as an explanation for previously reported associations between Se and T2D. Further clarification of longer term effects of Se is needed. CLINICAL TRIAL REGISTRY NIH Clinical Trials.gov number NCT00078897.
Collapse
Affiliation(s)
- Elizabeth Theresa Jacobs
- Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona
- University of Arizona Cancer Center, Tucson, Arizona
- Department of Nutritional Sciences, University of Arizona, Tucson, Arizona
| | - Peter Lance
- University of Arizona Cancer Center, Tucson, Arizona
- Department of Medicine, University of Arizona, Tucson, Arizona
| | - Lawrence J Mandarino
- Department of Medicine, University of Arizona, Tucson, Arizona
- Center for Disparities in Diabetes, Obesity and Metabolism, University of Arizona, Tucson, Arizona
| | | | | | - Janet Foote
- Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona
| | - Jessica A Martinez
- University of Arizona Cancer Center, Tucson, Arizona
- Department of Nutritional Sciences, University of Arizona, Tucson, Arizona
| | - Chiu-Hsieh Paul Hsu
- Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona
- University of Arizona Cancer Center, Tucson, Arizona
| | - Ken Batai
- Department of Surgery, University of Arizona, Tucson, Arizona
| | | | - Patricia A Thompson
- Department of Medicine, Stony Brook University, New York City, New York, USA
| |
Collapse
|
25
|
Shaibi GQ, Kullo IJ, Singh DP, Sharp RR, De Filippis E, Cuellar I, Hernandez V, Levey S, Radecki Breitkopf C, Olson JE, Cerhan JR, Mandarino LJ, Thibodeau SN, Lindor NM. Developing a Process for Returning Medically Actionable Genomic Variants to Latino Patients in a Federally Qualified Health Center. Public Health Genomics 2018; 21:77-84. [PMID: 30522109 DOI: 10.1159/000494488] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2018] [Accepted: 10/14/2018] [Indexed: 12/14/2022] Open
Abstract
AIM To develop a process for returning medically actionable genomic variants to Latino patients receiving care in a Federally Qualified Health Center. METHODS Prior to recruitment, researchers met with primary care providers to (1) orient clinicians to the project, (2) establish a process for returning actionable and nonactionable results to participants and providers through the electronic health record, and (3) develop a process for offering clinical decision support for follow-up education and care. A Community Advisory Board was engaged to provide input on recruitment strategies and materials for conveying results to participants. Participants in the Sangre Por Salud (Blood for Health) Biobank with hyperlipidemia or colon polyps represented the pool of potentially eligible participants. RESULTS A total of 1,621 individuals were invited to participate and 710 agreed to an in- person consenting visit (194 no-showed and 16 declined). Over 12-months, 500 participants were enrolled. Participants were primarily Spanish-speaking (81.6%), female (74.2%), and enrolled because of hyperlipidemia (95.4%). All but 2 participants opted to receive primary (i.e., related to enrollment phenotypes) as well as secondary actionable results. CONCLUSION Efforts to bring precision medicine to community-based health centers serving minority patients may require multilevel engagement activities to include individuals, providers, health systems, and the community.
Collapse
Affiliation(s)
- Gabriel Q Shaibi
- Center for Health Promotion and Disease Prevention, College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA,
| | - Iftikhar J Kullo
- Department of Cardiovascular Sciences, Mayo Clinic, Rochester, Minnesota, USA
| | | | - Richard R Sharp
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
| | | | - Idali Cuellar
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
| | | | - Sharon Levey
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
| | | | - Janet E Olson
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
| | - James R Cerhan
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
| | - Lawrence J Mandarino
- Division of Endocrinology, Department of Medicine, and Center for Disparities in Diabetes, Obesity, and Metabolism, University of Arizona, Tucson, Arizona, USA
| | - Stephen N Thibodeau
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
| | - Noralane M Lindor
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
26
|
Fonseca-Portilla R, Krell-Roesch J, Shaibi GQ, Caselli RJ, Mandarino LJ, Zhang N, Hentz JG, Coletta DK, de Filippis EA, Dawit S, Geda YE. Brain-Derived Neurotrophic Factor and Its Associations with Metabolism and Physical Activity in a Latino Sample. Metab Syndr Relat Disord 2018; 17:75-80. [PMID: 30418087 PMCID: PMC6484340 DOI: 10.1089/met.2018.0028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Background: Brain-derived neurotrophic factor (BDNF) is associated with body weight and other health conditions but remains understudied in the Latino population. The aim of this study was to examine the associations of BDNF serum levels with body mass index (BMI), physical activity, and the rs6265 nonconservative polymorphism among 349 Latinos aged ≥18 years enrolled in the Arizona Insulin Resistance Registry. Materials and Methods: Data on physical activity were acquired using a self-reported questionnaire. BDNF serum levels were measured utilizing a modified ELISA method, and the rs6265 polymorphism was genotyped by the Assay-by-Design service. Two sample t-tests or chi-squared tests were employed to compare demographics and outcomes between physically active and nonactive groups as well as between rs6265 CC and CT+TT groups. Results: BDNF levels and rs6265 polymorphism did not differ significantly between the physically active (N = 195) and nonactive group (N = 154). Participants with the rs6265 polymorphism did not show any significant difference in BDNF levels or BMI when compared with those with the normal functional variant. Higher BDNF levels were significantly associated with higher age (r = 0.11, P = 0.04) and higher 2-hr glucose level (r = 0.11, P = 0.04). Conclusions: In this cross-sectional study, the rs6265 polymorphism was not associated with a higher risk of obesity, or lower circulating levels of BDNF. Thus, the rs6265 polymorphism may have a different impact in Latinos as compared with other previously studied populations.
Collapse
Affiliation(s)
| | - Janina Krell-Roesch
- 2 Mayo Clinic Translational Neuroscience and Aging Program, Mayo Clinic, Scottsdale, Arizona
| | - Gabriel Q Shaibi
- 3 Center for Health Promotion and Disease Prevention, Arizona State University, Phoenix, Arizona
| | | | - Lawrence J Mandarino
- 5 Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona
| | - Nan Zhang
- 6 Department of Biostatistics, Mayo Clinic, Scottsdale, Arizona
| | - Joseph G Hentz
- 6 Department of Biostatistics, Mayo Clinic, Scottsdale, Arizona
| | - Dawn K Coletta
- 5 Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona
| | | | - Sara Dawit
- 4 Department of Neurology, Mayo Clinic, Scottsdale, Arizona
| | - Yonas E Geda
- 2 Mayo Clinic Translational Neuroscience and Aging Program, Mayo Clinic, Scottsdale, Arizona.,4 Department of Neurology, Mayo Clinic, Scottsdale, Arizona.,8 Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, Arizona
| |
Collapse
|
27
|
Tran L, Kras KA, Hoffman N, Ravichandran J, Dickinson JM, D’Lugos A, Carroll CC, Patel SH, Mandarino LJ, Roust L, Katsanos CS. Lower Fasted-State but Greater Increase in Muscle Protein Synthesis in Response to Elevated Plasma Amino Acids in Obesity. Obesity (Silver Spring) 2018; 26:1179-1187. [PMID: 29896930 PMCID: PMC6078204 DOI: 10.1002/oby.22213] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2017] [Revised: 04/16/2018] [Accepted: 04/17/2018] [Indexed: 12/14/2022]
Abstract
OBJECTIVE Obesity alters protein metabolism in skeletal muscle, but consistent evidence is lacking. This study compared muscle protein synthesis in adults with obesity and in lean controls in the fasted state and during an amino acid infusion. METHODS Ten subjects with obesity (age: 36 ± 3 years; BMI: 34 ± 1 kg/m2 ) and ten controls (age: 35 ± 3 years; BMI: 23 ± 1 kg/m2 ) received an infusion of L-[2,3,3,4,5,5,5,6,6,6-2 H10 ]leucine (0.15 μmol/kg fat-free mass/min) to measure muscle protein synthesis after an overnight fast and during amino acid infusion. RESULTS Despite greater muscle mammalian target of rapamycin phosphorylation (P ≤ 0.05), fasted-state mixed-muscle and mitochondrial protein synthesis were lower in subjects with obesity (P ≤ 0.05). However, the change in mixed-muscle protein synthesis during the amino acid infusion was 2.7-fold greater in subjects with obesity (P ≤ 0.05), accompanied by a greater change in S6 kinase-1 phosphorylation (P ≤ 0.05). The change in mitochondrial protein synthesis did not differ between groups (P > 0.05). CONCLUSIONS Adults with obesity have reduced muscle protein synthesis in the fasted state, but this response is compensated for by a greater change in overall muscle protein synthesis during amino acid infusion.
Collapse
Affiliation(s)
- Lee Tran
- Center for Metabolic and Vascular Biology, Arizona State University, Tempe, AZ
| | - Katon A. Kras
- Center for Metabolic and Vascular Biology, Arizona State University, Tempe, AZ
| | - Nyssa Hoffman
- Center for Metabolic and Vascular Biology, Arizona State University, Tempe, AZ
| | | | - Jared M. Dickinson
- School of Nutrition and Health Promotion, Arizona State University, Phoenix, AZ
| | - Andrew D’Lugos
- School of Nutrition and Health Promotion, Arizona State University, Phoenix, AZ
| | - Chad C. Carroll
- Department of Health and Kinesiology, Purdue University, West Lafayette, IN
| | - Shivam H. Patel
- Department of Health and Kinesiology, Purdue University, West Lafayette, IN
| | - Lawrence J. Mandarino
- Center for Metabolic and Vascular Biology, Arizona State University, Tempe, AZ
- College of Medicine, Mayo Clinic in Arizona, Scottsdale, AZ
| | - Lori Roust
- College of Medicine, Mayo Clinic in Arizona, Scottsdale, AZ
| | - Christos S. Katsanos
- Center for Metabolic and Vascular Biology, Arizona State University, Tempe, AZ
- College of Medicine, Mayo Clinic in Arizona, Scottsdale, AZ
| |
Collapse
|
28
|
Klimentidis YC, Raichlen DA, Bea J, Garcia DO, Wineinger NE, Mandarino LJ, Alexander GE, Chen Z, Going SB. Genome-wide association study of habitual physical activity in over 377,000 UK Biobank participants identifies multiple variants including CADM2 and APOE. Int J Obes (Lond) 2018; 42:1161-1176. [PMID: 29899525 PMCID: PMC6195860 DOI: 10.1038/s41366-018-0120-3] [Citation(s) in RCA: 201] [Impact Index Per Article: 33.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Revised: 04/03/2018] [Accepted: 04/30/2018] [Indexed: 12/18/2022]
Abstract
BACKGROUND/OBJECTIVES Physical activity (PA) protects against a wide range of diseases. Habitual PA appears to be heritable, motivating the search for specific genetic variants that may inform efforts to promote PA and target the best type of PA for each individual. SUBJECTS/METHODS We used data from the UK Biobank to perform the largest genome-wide association study of PA to date, using three measures based on self-report (nmax = 377,234) and two measures based on wrist-worn accelerometry data (nmax = 91,084). We examined genetic correlations of PA with other traits and diseases, as well as tissue-specific gene expression patterns. With data from the Atherosclerosis Risk in Communities (ARIC; n = 8,556) study, we performed a meta-analysis of our top hits for moderate-to-vigorous PA (MVPA). RESULTS We identified ten loci across all PA measures that were significant in both a basic and a fully adjusted model (p < 5 × 10-9). Upon meta-analysis of the nine top hits for MVPA with results from ARIC, eight were genome-wide significant. Interestingly, among these, the rs429358 variant in the APOE gene was the most strongly associated with MVPA, whereby the allele associated with higher Alzheimer's risk was associated with greater MVPA. However, we were not able to rule out possible selection bias underlying this result. Variants in CADM2, a gene previously implicated in obesity, risk-taking behavior and other traits, were found to be associated with habitual PA. We also identified three loci consistently associated (p < 5 × 10-5) with PA across both self-report and accelerometry, including CADM2. We found genetic correlations of PA with educational attainment, chronotype, psychiatric traits, and obesity-related traits. Tissue enrichment analyses implicate the brain and pituitary gland as locations where PA-associated loci may exert their actions. CONCLUSIONS These results provide new insight into the genetic basis of habitual PA, and the genetic links connecting PA with other traits and diseases.
Collapse
Affiliation(s)
- Yann C Klimentidis
- Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
| | | | - Jennifer Bea
- Department of Medicine, University of Arizona, Tucson, AZ, USA
- Department of Nutritional Sciences, University of Arizona, Tucson, AZ, USA
| | - David O Garcia
- Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
| | | | - Lawrence J Mandarino
- Center for Disparities in Diabetes, Obesity and Metabolism, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Arizona, Tucson, AZ, USA
| | - Gene E Alexander
- Departments of Psychology and Psychiatry, Neuroscience and Physiological Sciences Interdisciplinary Programs, BIO5 Institute, and Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, AZ, USA
- Arizona Alzheimer's Consortium, Phoenix, AZ, USA
| | - Zhao Chen
- Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
| | - Scott B Going
- Department of Nutritional Sciences, University of Arizona, Tucson, AZ, USA
| |
Collapse
|
29
|
Willis WT, Miranda-Grandjean D, Hudgens J, Willis EA, Finlayson J, De Filippis EA, Zapata Bustos R, Langlais PR, Mielke C, Mandarino LJ. Dominant and sensitive control of oxidative flux by the ATP-ADP carrier in human skeletal muscle mitochondria: Effect of lysine acetylation. Arch Biochem Biophys 2018; 647:93-103. [PMID: 29653079 DOI: 10.1016/j.abb.2018.04.006] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2018] [Revised: 03/29/2018] [Accepted: 04/08/2018] [Indexed: 02/01/2023]
Abstract
The adenine nucleotide translocase (ANT) of the mitochondrial inner membrane exchanges ADP for ATP. Mitochondria were isolated from human vastus lateralis muscle (n = 9). Carboxyatractyloside titration of O2 consumption rate (Jo) at clamped [ADP] of 21 μM gave ANT abundance of 0.97 ± 0.14 nmol ANT/mg and a flux control coefficient of 82% ± 6%. Flux control fell to 1% ± 1% at saturating (2 mM) [ADP]. The KmADP for Jo was 32.4 ± 1.8 μM. In terms of the free (-3) ADP anion this KmADP was 12.0 ± 0.7 μM. A novel luciferase-based assay for ATP production gave KmADP of 13.1 ± 1.9 μM in the absence of ATP competition. The free anion KmADP in this case was 2.0 ± 0.3 μM. Targeted proteomic analyses showed significant acetylation of ANT Lysine23 and that ANT1 was the most abundant isoform. Acetylation of Lysine23 correlated positively with KmADP, r = 0.74, P = 0.022. The findings underscore the central role played by ANT in the control of oxidative phosphorylation, particularly at the energy phosphate levels associated with low ATP demand. As predicted by molecular dynamic modeling, ANT Lysine23 acetylation decreased the apparent affinity of ADP for ANT binding.
Collapse
Affiliation(s)
- W T Willis
- University of Arizona, College of Medicine, Department of Medicine, 1501 N. Campbell Avenue, P.O. Box 245099, Tucson, AZ 85724-5099, USA.
| | - D Miranda-Grandjean
- Mayo Clinic, Division of Endocrinology, East Shea Boulevard and 134th Street, Scottsdale, AZ 85259, USA.
| | - J Hudgens
- Mayo Clinic, Division of Endocrinology, East Shea Boulevard and 134th Street, Scottsdale, AZ 85259, USA.
| | - E A Willis
- Mayo Clinic, Division of Endocrinology, East Shea Boulevard and 134th Street, Scottsdale, AZ 85259, USA.
| | - J Finlayson
- University of Arizona, College of Medicine, Department of Medicine, 1501 N. Campbell Avenue, P.O. Box 245099, Tucson, AZ 85724-5099, USA.
| | - E A De Filippis
- Mayo Clinic, Division of Endocrinology, East Shea Boulevard and 134th Street, Scottsdale, AZ 85259, USA.
| | - R Zapata Bustos
- University of Arizona, College of Medicine, Department of Medicine, 1501 N. Campbell Avenue, P.O. Box 245099, Tucson, AZ 85724-5099, USA.
| | - P R Langlais
- University of Arizona, College of Medicine, Department of Medicine, 1501 N. Campbell Avenue, P.O. Box 245099, Tucson, AZ 85724-5099, USA.
| | - C Mielke
- Mayo Clinic, Division of Endocrinology, East Shea Boulevard and 134th Street, Scottsdale, AZ 85259, USA.
| | - L J Mandarino
- University of Arizona, College of Medicine, Department of Medicine, 1501 N. Campbell Avenue, P.O. Box 245099, Tucson, AZ 85724-5099, USA.
| |
Collapse
|
30
|
Day SE, Garcia LA, Coletta RL, Campbell LE, Benjamin TR, De Filippis EA, Madura JA, Mandarino LJ, Roust LR, Coletta DK. Alterations of sorbin and SH3 domain containing 3 (SORBS3) in human skeletal muscle following Roux-en-Y gastric bypass surgery. Clin Epigenetics 2017; 9:96. [PMID: 28883895 PMCID: PMC5581422 DOI: 10.1186/s13148-017-0396-5] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2017] [Accepted: 08/24/2017] [Indexed: 12/14/2022] Open
Abstract
Background Obesity is a disease that is caused by genetic and environmental factors. However, epigenetic mechanisms of obesity are less well known. DNA methylation provides a mechanism whereby environmental factors can influence gene transcription. The aim of our study was to investigate skeletal muscle DNA methylation of sorbin and SH3 domain containing 3 (SORBS3) with weight loss induced by Roux-en-Y gastric bypass (RYGB). Results Previously, we had shown increased methylation (5.0 to 24.4%) and decreased gene expression (fold change − 1.9) of SORBS3 with obesity (BMI > 30 kg/m2) compared to lean controls. In the present study, basal muscle biopsies were obtained from seven morbidly obese (BMI > 40 kg/m2) female subjects pre- and 3 months post-RYGB surgery, in combination with euglycemic-hyperinsulinemic clamps to assess insulin sensitivity. We identified 30 significantly altered promoter and untranslated region methylation sites in SORBS3 using reduced representation bisulfite sequencing (RRBS). Twenty-nine of these sites were decreased (− 5.6 to − 24.2%) post-RYGB compared to pre-RYGB. We confirmed the methylation in 2 (Chr.8:22,423,690 and Chr.8:22,423,702) of the 29 decreased SORBS3 sites using pyrosequencing. This decreased methylation was associated with an increase in SORBS3 gene expression (fold change + 1.7) post-surgery. In addition, we demonstrated that SORBS3 promoter methylation in vitro significantly alters reporter gene expression (P < 0.0001). Two of the SORBS3 methylation sites (Chr.8:22,423,111 and Chr.8:22,423,205) were strongly correlated with fasting plasma glucose levels (r = 0.9, P = 0.00009 and r = 0.8, P = 0.0010). Changes in SORBS3 gene expression post-surgery were correlated with obesity measures and fasting insulin levels (r = 0.5 to 0.8; P < 0.05). Conclusions These results demonstrate that SORBS3 methylation and gene expression are altered in obesity and restored to normal levels through weight loss induced by RYGB surgery.
Collapse
Affiliation(s)
- Samantha E Day
- School of Life Sciences, Arizona State University, Tempe, AZ USA
| | - Luis A Garcia
- Department of Medicine, The University of Arizona College of Medicine, PO Box 245035, 1501 N. Campbell Ave, Tucson, AZ 85724-5035 USA
| | - Richard L Coletta
- Department of Medicine, The University of Arizona College of Medicine, PO Box 245035, 1501 N. Campbell Ave, Tucson, AZ 85724-5035 USA
| | | | - Tonya R Benjamin
- Endocrinology Department, Mayo Clinic in Arizona, Scottsdale, AZ USA
| | | | - James A Madura
- Endocrinology Department, Mayo Clinic in Arizona, Scottsdale, AZ USA
| | - Lawrence J Mandarino
- Department of Medicine, The University of Arizona College of Medicine, PO Box 245035, 1501 N. Campbell Ave, Tucson, AZ 85724-5035 USA
| | - Lori R Roust
- Endocrinology Department, Mayo Clinic in Arizona, Scottsdale, AZ USA
| | - Dawn K Coletta
- Department of Medicine, The University of Arizona College of Medicine, PO Box 245035, 1501 N. Campbell Ave, Tucson, AZ 85724-5035 USA.,Department of Basic Medical Sciences, The University of Arizona College of Medicine - Phoenix, Phoenix, AZ USA
| |
Collapse
|
31
|
Luo M, Mengos AE, Ma W, Finlayson J, Bustos RZ, Xiao Zhu Y, Shi CX, Stubblefield TM, Willis WT, Mandarino LJ. Characterization of the novel protein KIAA0564 (Von Willebrand Domain-containing Protein 8). Biochem Biophys Res Commun 2017; 487:545-551. [PMID: 28414126 PMCID: PMC5824621 DOI: 10.1016/j.bbrc.2017.04.067] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2017] [Accepted: 04/13/2017] [Indexed: 11/28/2022]
Abstract
The VWA8 gene was first identified by the Kazusa cDNA project and named KIAA0564. Based on the observation, by similarity, that the protein encoded by KIAA0564 contains a Von Willebrand Factor 8 domain, KIAA0564 was named Von Willebrand Domain-containing Protein 8 (VWA8). The function of VWA8 protein is almost unknown. The purpose of this study was to characterize the tissue distribution, cellular location, and function of VWA8. In mice VWA8 protein was mostly distributed in liver, kidney, heart, pancreas and skeletal muscle, and is present as a long isoform and a shorter splice variant (VWA8a and VWA8b). VWA8 protein and mRNA were elevated in mouse liver in response to high fat feeding. Sequence analysis suggests that VWA8 has a mitochondrial targeting sequence and domains responsible for ATPase activity. VWA8 protein was targeted exclusively to mitochondria in mouse AML12 liver cells, and this was prevented by deletion of the targeting sequence. Moreover, the VWA8 short isoform overexpressed in insect cells using a baculovirus construct had in vitro ATPase activity. Deletion of the Walker A motif or Walker B motif in VWA8 mostly blocked ATPase activity, suggesting Walker A motif or Walker B motif are essential to the ATPase activity of VWA8. Finally, homology modeling suggested that VWA8 may have a structure most confidently similar to dynein motor proteins.
Collapse
Affiliation(s)
- Moulun Luo
- Division of Endocrinology, University of Arizona, Tucson, AZ, United States
| | - April E Mengos
- Division of Laboratory Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States
| | - Wuqiong Ma
- Division of Endocrinology, University of Arizona, Tucson, AZ, United States
| | - Jean Finlayson
- Division of Endocrinology, University of Arizona, Tucson, AZ, United States
| | | | - Yuan Xiao Zhu
- Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ, United States
| | - Chang-Xin Shi
- Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ, United States
| | - Tianna M Stubblefield
- Mouse Metabolic Phenotyping Laboratory, Mayo Clinic Arizona, Scottsdale, AZ, United States
| | - Wayne T Willis
- Division of Endocrinology, University of Arizona, Tucson, AZ, United States
| | | |
Collapse
|
32
|
Kruse R, Krantz J, Barker N, Coletta RL, Rafikov R, Luo M, Højlund K, Mandarino LJ, Langlais PR. Characterization of the CLASP2 Protein Interaction Network Identifies SOGA1 as a Microtubule-Associated Protein. Mol Cell Proteomics 2017; 16:1718-1735. [PMID: 28550165 DOI: 10.1074/mcp.ra117.000011] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2017] [Indexed: 12/26/2022] Open
Abstract
CLASP2 is a microtubule-associated protein that undergoes insulin-stimulated phosphorylation and co-localization with reorganized actin and GLUT4 at the plasma membrane. To gain insight to the role of CLASP2 in this system, we developed and successfully executed a streamlined interactome approach and built a CLASP2 protein network in 3T3-L1 adipocytes. Using two different commercially available antibodies for CLASP2 and an antibody for epitope-tagged, overexpressed CLASP2, we performed multiple affinity purification coupled with mass spectrometry (AP-MS) experiments in combination with label-free quantitative proteomics and analyzed the data with the bioinformatics tool Significance Analysis of Interactome (SAINT). We discovered that CLASP2 coimmunoprecipitates (co-IPs) the novel protein SOGA1, the microtubule-associated protein kinase MARK2, and the microtubule/actin-regulating protein G2L1. The GTPase-activating proteins AGAP1 and AGAP3 were also enriched in the CLASP2 interactome, although subsequent AGAP3 and CLIP2 interactome analysis suggests a preference of AGAP3 for CLIP2. Follow-up MARK2 interactome analysis confirmed reciprocal co-IP of CLASP2 and revealed MARK2 can co-IP SOGA1, glycogen synthase, and glycogenin. Investigating the SOGA1 interactome confirmed SOGA1 can reciprocal co-IP both CLASP2 and MARK2 as well as glycogen synthase and glycogenin. SOGA1 was confirmed to colocalize with CLASP2 and with tubulin, which identifies SOGA1 as a new microtubule-associated protein. These results introduce the metabolic function of these proposed novel protein networks and their relationship with microtubules as new fields of cytoskeleton-associated protein biology.
Collapse
Affiliation(s)
- Rikke Kruse
- From the ‡The Section of Molecular Diabetes & Metabolism, Department of Clinical Research and Institute of Molecular Medicine, University of Southern Denmark, DK-5000 Odense, Denmark.,§Department of Endocrinology, Odense University Hospital, DK-5000 Odense, Denmark
| | - James Krantz
- ¶Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona 85721
| | - Natalie Barker
- ¶Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona 85721
| | - Richard L Coletta
- ‖School of Life Sciences, Arizona State University, Tempe, Arizona 85787
| | - Ruslan Rafikov
- ¶Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona 85721
| | - Moulun Luo
- ¶Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona 85721
| | - Kurt Højlund
- From the ‡The Section of Molecular Diabetes & Metabolism, Department of Clinical Research and Institute of Molecular Medicine, University of Southern Denmark, DK-5000 Odense, Denmark.,§Department of Endocrinology, Odense University Hospital, DK-5000 Odense, Denmark
| | - Lawrence J Mandarino
- ¶Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona 85721
| | - Paul R Langlais
- ¶Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona 85721;
| |
Collapse
|
33
|
Day SE, Coletta RL, Kim JY, Garcia LA, Campbell LE, Benjamin TR, Roust LR, De Filippis EA, Mandarino LJ, Coletta DK. Potential epigenetic biomarkers of obesity-related insulin resistance in human whole-blood. Epigenetics 2017; 12:254-263. [PMID: 28106509 DOI: 10.1080/15592294.2017.1281501] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Obesity can increase the risk of complex metabolic diseases, including insulin resistance. Moreover, obesity can be caused by environmental and genetic factors. However, the epigenetic mechanisms of obesity are not well defined. Therefore, the identification of novel epigenetic biomarkers of obesity allows for a more complete understanding of the disease and its underlying insulin resistance. The aim of our study was to identify DNA methylation changes in whole-blood that were strongly associated with obesity and insulin resistance. Whole-blood was obtained from lean (n = 10; BMI = 23.6 ± 0.7 kg/m2) and obese (n = 10; BMI = 34.4 ± 1.3 kg/m2) participants in combination with euglycemic hyperinsulinemic clamps to assess insulin sensitivity. We performed reduced representation bisulfite sequencing on genomic DNA isolated from the blood. We identified 49 differentially methylated cytosines (DMCs; q < 0.05) that were altered in obese compared with lean participants. We identified 2 sites (Chr.21:46,957,981 and Chr.21:46,957,915) in the 5' untranslated region of solute carrier family 19 member 1 (SLC19A1) with decreased methylation in obese participants (lean 0.73 ± 0.11 vs. obese 0.09 ± 0.05; lean 0.68 ± 0.10 vs. obese 0.09 ± 0.05, respectively). These 2 DMCs identified by obesity were also significantly predicted by insulin sensitivity (r = 0.68, P = 0.003; r = 0.66; P = 0.004). In addition, we performed a differentially methylated region (DMR) analysis and demonstrated a decrease in methylation of Chr.21:46,957,915-46,958,001 in SLC19A1 of -34.9% (70.4% lean vs. 35.5% obese). The decrease in whole-blood SLC19A1 methylation in our obese participants was similar to the change observed in skeletal muscle (Chr.21:46,957,981, lean 0.70 ± 0.09 vs. obese 0.31 ± 0.11 and Chr.21:46,957,915, lean 0.72 ± 0.11 vs. obese 0.31 ± 0.13). Pyrosequencing analysis further demonstrated a decrease in methylation at Chr.21:46,957,915 in both whole-blood (lean 0.71 ± 0.10 vs. obese 0.18 ± 0.06) and skeletal muscle (lean 0.71 ± 0.10 vs. obese 0.30 ± 0.11). Our findings demonstrate a new potential epigenetic biomarker, SLC19A1, for obesity and its underlying insulin resistance.
Collapse
Affiliation(s)
- Samantha E Day
- a School of Life Sciences , Arizona State University , Tempe , AZ , USA
| | - Richard L Coletta
- b School for the Science of Health Care Delivery , Arizona State University , Phoenix , AZ , USA
| | - Joon Young Kim
- c Division of Weight Management and Wellness , Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center , Pittsburgh , PA , USA
| | - Luis A Garcia
- b School for the Science of Health Care Delivery , Arizona State University , Phoenix , AZ , USA
| | - Latoya E Campbell
- a School of Life Sciences , Arizona State University , Tempe , AZ , USA
| | - Tonya R Benjamin
- d Endocrinology Department , Mayo Clinic in Arizona , Scottsdale , AZ , USA
| | - Lori R Roust
- d Endocrinology Department , Mayo Clinic in Arizona , Scottsdale , AZ , USA
| | | | - Lawrence J Mandarino
- e Department of Medicine , The University of Arizona College of Medicine , Tucson , AZ , USA
| | - Dawn K Coletta
- e Department of Medicine , The University of Arizona College of Medicine , Tucson , AZ , USA.,f Department of Basic Medical Sciences , The University of Arizona College of Medicine , Phoenix , AZ , USA
| |
Collapse
|
34
|
Campbell LE, Langlais PR, Day SE, Coletta RL, Benjamin TR, De Filippis EA, Madura JA, Mandarino LJ, Roust LR, Coletta DK. Identification of Novel Changes in Human Skeletal Muscle Proteome After Roux-en-Y Gastric Bypass Surgery. Diabetes 2016; 65:2724-31. [PMID: 27207528 PMCID: PMC5001187 DOI: 10.2337/db16-0004] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/02/2016] [Accepted: 04/29/2016] [Indexed: 12/18/2022]
Abstract
The mechanisms of metabolic improvements after Roux-en-Y gastric bypass (RYGB) surgery are not entirely clear. Therefore, the aim of our study was to investigate the role of obesity and RYGB on the human skeletal muscle proteome. Basal muscle biopsies were obtained from seven obese (BMI >40 kg/m(2)) female subjects (45.1 ± 3.6 years) pre- and 3 months post-RYGB, and euglycemic-hyperinsulinemic clamps were used to assess insulin sensitivity. Four age-matched (48.5 ± 4.7 years) lean (BMI <25 kg/m(2)) females served as control subjects. We performed quantitative mass spectrometry and microarray analyses on protein and RNA isolated from the muscle biopsies. Significant improvements in fasting plasma glucose (104.2 ± 7.8 vs. 86.7 ± 3.1 mg/dL) and BMI (42.1 ± 2.2 vs. 35.3 ± 1.8 kg/m(2)) were demonstrated in the pre- versus post-RYGB, both P < 0.05. Proteomic analysis identified 2,877 quantifiable proteins. Of these, 395 proteins were significantly altered in obesity before surgery, and 280 proteins differed significantly post-RYGB. Post-RYGB, 49 proteins were returned to normal levels after surgery. KEGG pathway analysis revealed a decreased abundance in ribosomal and oxidative phosphorylation proteins in obesity, and a normalization of ribosomal proteins post-RYGB. The transcriptomic data confirmed the normalization of the ribosomal proteins. Our results provide evidence that obesity and RYGB have a dynamic effect on the skeletal muscle proteome.
Collapse
Affiliation(s)
| | | | - Samantha E Day
- School of Life Sciences, Arizona State University, Tempe, AZ
| | - Richard L Coletta
- School for the Science of Health Care Delivery, Arizona State University, Phoenix, AZ
| | | | | | | | - Lawrence J Mandarino
- Mayo Clinic, Scottsdale, AZ School for the Science of Health Care Delivery, Arizona State University, Phoenix, AZ
| | | | - Dawn K Coletta
- Mayo Clinic, Scottsdale, AZ School for the Science of Health Care Delivery, Arizona State University, Phoenix, AZ Department of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, AZ
| |
Collapse
|
35
|
Miyazaki Y, De Filippis E, Bajaj M, Wajcberg E, Glass L, Triplitt C, Cersosimo E, Mandarino LJ, Defronzo RA. Predictors of improved glycaemic control with rosiglitazone therapy in type 2 diabetic patients: a practical approach for the primary care physician. ACTA ACUST UNITED AC 2016. [DOI: 10.1177/14746514050050010601] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Objective — To determine predictors of improved glycaemic control in patients with type 2 diabetes mellitus during rosiglitazone therapy using basic clinical parameters that are readily available in daily clinical practice. Research design and methods — Thirty-seven type 2 diabetic patients (men/women = 18/19; age = 54±2years; diabetes duration = 6±1 years; diet-/sulphonylurea-treated = 24/13) received a 75 g oral glucose tolerance test (OGTT) and determination of body fat before and after rosiglitazone (8 mg/day) for 12 weeks. Results — After rosiglitazone therapy, there were decreases in HbA1C (8.6±0.2 to 7.2±0.2%, p<0.0001), fasting plasma glucose (FPG) (10.6±0.3 to 8.0±0.3 mmol/L [191±6 to 145±6 mg/dL], p<0.0001), fasting plasma insulin (FPI) (108±6 to 84±6 pmol/L [18±1 to 14±µU/ml], p<0.05), fasting free fatty acids (FFA) (760±39 to 611±33 µEq/l, p<0.05), mean plasma glucose (PG) — OGTT (16.2±0.39 to 12.7±0.33 mmol/L [291±7 to 230±6 mg/dL], p<0.001), and mean FFA-OGTT (604±27 to 445±23 µEq/l, p<0.01) despite increases in body weight (85±2 to 88±2 kg, p<0.01) and % fat mass (37.9±2.0 to 39.5±1.9%, p<0.01). The insulinogenic index (IGI) during 0—120 minutes OGTT (IGI0-120) increased following rosiglitazone (0.19±0.03 to 0.30±0.05, p<0.01). Two different insulin sensitivity indices, calculated from PG and plasma insulin (PI) during OGTT, increased significantly: composite index of whole body insulin sensitivity (ISIcomposite): 2.3±0.3 to 3.4±0.4, p<0.05; oral glucose insulin sensitivity (OGIS): 248±5 to 294±6 ml/m2.min, p<0.001. Using clinical and laboratory variables obtained in daily clinical practice (age, gender, diabetes duration, sulphonylurea treatment, body mass index (BMI), % fat mass, fasting plasma insulin/C-peptide/FFA/lipids, IGI0-30, IGI0-120, and ISIcomposite or OGIS), stepwise regression analysis demonstrated that % fat mass (standard coefficient (S.C.) = —0.49, p=0.001) and OGIS (S.C. = 0.31, p=0.02) or ISIcomp (S.C. = 0.31, p=0.03) are significant predictors of the decrease in HbA1C after rosiglitazone (adjusted R2 =0.33, p=0.0004). Conclusions — Rosiglitazone improves insulin resistance and glycaemic control in type 2 diabetes. Obesity (more body fat mass) and reduced insulin sensitivity prior to treatment are the best predictors of glycaemic response to thiazolidinedione therapy in type 2 diabetes.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Ralph A Defronzo
- University of Texas Health Science Center, Diabetes Division, Room 3.380S, 7703 Floyd Curl Drive, San Antonio, Texas, 78229-3900, USA,
| |
Collapse
|
36
|
Day SE, Coletta RL, Kim JY, Campbell LE, Benjamin TR, Roust LR, De Filippis EA, Dinu V, Shaibi GQ, Mandarino LJ, Coletta DK. Next-generation sequencing methylation profiling of subjects with obesity identifies novel gene changes. Clin Epigenetics 2016; 8:77. [PMID: 27437034 PMCID: PMC4950754 DOI: 10.1186/s13148-016-0246-x] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2016] [Accepted: 07/11/2016] [Indexed: 01/06/2023] Open
Abstract
Background Obesity is a metabolic disease caused by environmental and genetic factors. However, the epigenetic mechanisms of obesity are incompletely understood. The aim of our study was to investigate the role of skeletal muscle DNA methylation in combination with transcriptomic changes in obesity. Results Muscle biopsies were obtained basally from lean (n = 12; BMI = 23.4 ± 0.7 kg/m2) and obese (n = 10; BMI = 32.9 ± 0.7 kg/m2) participants in combination with euglycemic-hyperinsulinemic clamps to assess insulin sensitivity. We performed reduced representation bisulfite sequencing (RRBS) next-generation methylation and microarray analyses on DNA and RNA isolated from vastus lateralis muscle biopsies. There were 13,130 differentially methylated cytosines (DMC; uncorrected P < 0.05) that were altered in the promoter and untranslated (5' and 3'UTR) regions in the obese versus lean analysis. Microarray analysis revealed 99 probes that were significantly (corrected P < 0.05) altered. Of these, 12 genes (encompassing 22 methylation sites) demonstrated a negative relationship between gene expression and DNA methylation. Specifically, sorbin and SH3 domain containing 3 (SORBS3) which codes for the adapter protein vinexin was significantly decreased in gene expression (fold change −1.9) and had nine DMCs that were significantly increased in methylation in obesity (methylation differences ranged from 5.0 to 24.4 %). Moreover, differentially methylated region (DMR) analysis identified a region in the 5'UTR (Chr.8:22,423,530–22,423,569) of SORBS3 that was increased in methylation by 11.2 % in the obese group. The negative relationship observed between DNA methylation and gene expression for SORBS3 was validated by a site-specific sequencing approach, pyrosequencing, and qRT-PCR. Additionally, we performed transcription factor binding analysis and identified a number of transcription factors whose binding to the differentially methylated sites or region may contribute to obesity. Conclusions These results demonstrate that obesity alters the epigenome through DNA methylation and highlights novel transcriptomic changes in SORBS3 in skeletal muscle. Electronic supplementary material The online version of this article (doi:10.1186/s13148-016-0246-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Samantha E Day
- School of Life Sciences, Arizona State University, Tempe, AZ USA
| | - Richard L Coletta
- School for the Science of Health Care Delivery, Arizona State University, Phoenix, AZ USA
| | - Joon Young Kim
- Division of Weight Management and Wellness Children's Hospital of Pittsburgh, Pittsburgh, PA USA
| | | | - Tonya R Benjamin
- Endocrinology Department, Mayo Clinic in Arizona, Scottsdale, AZ USA
| | - Lori R Roust
- Endocrinology Department, Mayo Clinic in Arizona, Scottsdale, AZ USA
| | | | - Valentin Dinu
- The Department of Biomedical Informatics, Arizona State University, Phoenix, AZ USA
| | - Gabriel Q Shaibi
- College of Nursing and Health Innovation Arizona State University, Phoenix, AZ USA ; Mayo/ASU Center for Metabolic and Vascular Biology, Mayo Clinic in Arizona, Scottsdale, AZ USA
| | - Lawrence J Mandarino
- Division of Endocrinology, Diabetes and Metabolism in the Department of Medicine at the UA College of Medicine, University of Arizona, Tucson, AZ USA
| | - Dawn K Coletta
- Mayo/ASU Center for Metabolic and Vascular Biology, Mayo Clinic in Arizona, Scottsdale, AZ USA ; School of Nutrition and Health Promotion, College of Health Solutions, Arizona State University, 550 N. 3rd Street, Phoenix, AZ 85004 USA ; Department of Basic Medical Sciences, The University of Arizona College of Medicine, Phoenix, AZ USA
| |
Collapse
|
37
|
Xu Q, Hou YX, Langlais P, Erickson P, Zhu J, Shi CX, Luo M, Zhu Y, Xu Y, Mandarino LJ, Stewart K, Chang XB. Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival. BMC Cancer 2016; 16:297. [PMID: 27142104 PMCID: PMC4855823 DOI: 10.1186/s12885-016-2331-0] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2015] [Accepted: 04/29/2016] [Indexed: 01/22/2023] Open
Abstract
BACKGROUND Immunomodulatory drugs (IMiDs), such as lenalidomide, are therapeutically active compounds that bind and modulate the E3 ubiquitin ligase substrate recruiter cereblon, thereby affect steady-state levels of cereblon and cereblon binding partners, such as ikaros and aiolos, and induce many cellular responses, including cytotoxicity to multiple myeloma (MM) cells. Nevertheless, it takes many days for MM cells to die after IMiD induced depletion of ikaros and aiolos and thus we searched for other cereblon binding partners that participate in IMiD cytotoxicity. METHODS Cereblon binding partners were identified from a MM cell line expressing histidine-tagged cereblon by pulling down cereblon and its binding partners and verified by co-immunoprecipitation. IMiD effects were determined by western blot analysis, cell viability assay, microRNA array and apoptosis analysis. RESULTS We identified argonaute 2 (AGO2) as a cereblon binding partner and found that the steady-state levels of AGO2 were regulated by cereblon. Upon treatment of IMiD-sensitive MM cells with lenalidomide, the steady-state levels of cereblon were significantly increased, whereas levels of AGO2 were significantly decreased. It has been reported that AGO2 plays a pivotal role in microRNA maturation and function. Interestingly, upon treatment of MM cells with lenalidomide, the steady-state levels of microRNAs were significantly altered. In addition, silencing of AGO2 in MM cells, regardless of sensitivity to IMiDs, significantly decreased the levels of AGO2 and microRNAs and massively induced cell death. CONCLUSION These results support the notion that the cereblon binding partner AGO2 plays an important role in regulating MM cell growth and survival and AGO2 could be considered as a novel drug target for overcoming IMiD resistance in MM cells.
Collapse
Affiliation(s)
- Qinqin Xu
- Department of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ, 85259, USA.,Zhejiang Provincial Key Laboratory of Nephrology, Hangzhou Traditional Chinese Medical Hospital, 453 Tiyuchang Rd, Hangzhou, 310007, China
| | - Yue-xian Hou
- Department of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ, 85259, USA
| | - Paul Langlais
- Department of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ, 85259, USA
| | - Patrick Erickson
- Department of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ, 85259, USA
| | - James Zhu
- Department of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ, 85259, USA
| | - Chang-Xin Shi
- Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | - Moulun Luo
- Center for Metabolic and Vascular Biology, Arizona State University, Tempe, AZ, USA
| | - Yuanxiao Zhu
- Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | - Ye Xu
- Department of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ, 85259, USA.,Key Laboratory of Carcinogenesis and Translational Research, Breast Center, Beijing Cancer Hospital & Institute, Peking University Cancer Hospital, Beijing, 100142, P. R. China
| | - Lawrence J Mandarino
- Center for Metabolic and Vascular Biology, Arizona State University, Tempe, AZ, USA.,Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | - Keith Stewart
- Division of Hematology-Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | - Xiu-bao Chang
- Department of Biochemistry & Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, 13400 E. Shea Boulevard, Scottsdale, AZ, 85259, USA.
| |
Collapse
|
38
|
Affiliation(s)
- Moulun Luo
- ASU/Mayo Center for Metabolic and Vascular Biology, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | - April E Mengos
- ASU/Mayo Center for Metabolic and Vascular Biology, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | - Lawrence J Mandarino
- ASU/Mayo Center for Metabolic and Vascular Biology, Mayo Clinic Arizona, Scottsdale, AZ, USA.,Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | | |
Collapse
|
39
|
Kim JY, DeMenna JT, Puppala S, Chittoor G, Schneider J, Duggirala R, Mandarino LJ, Shaibi GQ, Coletta DK. Physical activity and FTO genotype by physical activity interactive influences on obesity. BMC Genet 2016; 17:47. [PMID: 26908368 PMCID: PMC4765034 DOI: 10.1186/s12863-016-0357-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2015] [Accepted: 02/17/2016] [Indexed: 01/16/2023] Open
Abstract
Background Although the effect of the fat mass and obesity-associated (FTO) gene on adiposity is well established, there is a lack of evidence whether physical activity (PA) modifies the effect of FTO variants on obesity in Latino populations. Therefore, the purpose of this study was to examine PA influences and interactive effects between FTO variants and PA on measures of adiposity in Latinos. Results After controlling for age and sex, participants who did not engage in regular PA exhibited higher BMI, fat mass, HC, and WC with statistical significance (P < 0.001). Although significant associations between the three FTO genotypes and adiposity measures were found, none of the FTO genotype by PA interaction assessments revealed nominally significant associations. However, several of such interactive influences exhibited considerable trend towards association. Conclusions These data suggest that adiposity measures are associated with PA and FTO variants in Latinos, but the impact of their interactive influences on these obesity measures appear to be minimal. Future studies with large sample sizes may help to determine whether individuals with specific FTO variants exhibit differential responses to PA interventions. Electronic supplementary material The online version of this article (doi:10.1186/s12863-016-0357-6) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Joon Young Kim
- Kinesiology Program, School of Nutrition and Health Promotion, Arizona State University, Phoenix, AZ, USA.
| | - Jacob T DeMenna
- College of Health Solutions, School for the Science of Health Care Delivery, Arizona State University, 550N. 3rd Street, Phoenix, 85004, AZ, USA.
| | - Sobha Puppala
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA.
| | - Geetha Chittoor
- Department of Nutrition and UNC Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, NC, USA.
| | - Jennifer Schneider
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX, USA.
| | - Ravindranath Duggirala
- South Texas Diabetes and Obesity Institute Edinburg Regional Academic Health Center University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
| | - Lawrence J Mandarino
- College of Health Solutions, School for the Science of Health Care Delivery, Arizona State University, 550N. 3rd Street, Phoenix, 85004, AZ, USA. .,Mayo/ASU Center for Metabolic and Vascular Biology, Phoenix, AZ, USA.
| | - Gabriel Q Shaibi
- Kinesiology Program, School of Nutrition and Health Promotion, Arizona State University, Phoenix, AZ, USA. .,Mayo/ASU Center for Metabolic and Vascular Biology, Phoenix, AZ, USA. .,College of Nursing & Health Innovation, Arizona State University, Phoenix, AZ, USA.
| | - Dawn K Coletta
- College of Health Solutions, School for the Science of Health Care Delivery, Arizona State University, 550N. 3rd Street, Phoenix, 85004, AZ, USA. .,Mayo/ASU Center for Metabolic and Vascular Biology, Phoenix, AZ, USA.
| |
Collapse
|
40
|
Beeman SC, Mandarino LJ, Georges JF, Bennett KM. Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non-alcoholic steatohepatitis. Magn Reson Med 2016; 70:1728-38. [PMID: 23390010 DOI: 10.1002/mrm.24619] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
PURPOSE The goal of this work was to detect disease-related microstructural changes to the liver using magnetic resonance imaging. Chronic liver disease can cause microstructural changes in the liver that reduce plasma access to the perisinusoidal space--the site of exchange between the blood plasma and the hepatic parenchyma. The reduced plasma access to the perisinusoidal space inhibits hepatic function and contributes to the ∼30,000 chronic liver disease-related deaths per year. METHODS The extracellular matrix-specific cationized ferritin magnetic resonance imaging probe was injected intravenously into healthy rats and a rat model of the chronic liver disease non-alcoholic steatohepatitis. Rats were subsequently imaged with T2*-weighted magnetic resonance imaging. RESULTS This work demonstrates that the binding of cationized ferritin to the perisinusoidal extracellular matrix is reduced by 55% in a rat model of non-alcoholic steatohepatitis compared to healthy controls. This reduced binding is detectable in vivo with magnetic resonance imaging. Immunofluorescence and electron microscopy indicated that the reduced binding is due to inhibited macromolecular access to the perisinusoidal space caused by non-alcoholic steatohepatitis-related microstructural changes. CONCLUSIONS The reduced accumulation of intravenously injected cationized ferritin may report on changes in macromolecular access to the liver parenchyma in chronic liver disease.
Collapse
Affiliation(s)
- Scott C Beeman
- Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee
| | | | | | | |
Collapse
|
41
|
González-García ZM, Kullo IJ, Coletta DK, Mandarino LJ, Shaibi GQ. Osteocalcin and type 2 diabetes risk in Latinos: a life course approach. Am J Hum Biol 2015; 27:859-61. [PMID: 26088710 DOI: 10.1002/ajhb.22745] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2015] [Revised: 04/09/2015] [Accepted: 05/07/2015] [Indexed: 01/08/2023] Open
Abstract
OBJECTIVE To examine associations between circulating levels of the bone-derived protein osteocalcin (OC) and type 2 diabetes (T2D) risk in Latino children and adults. METHODS Serum OC was measured in 136 children and 531 adults who had the following T2D risk factors assessed, body mass index (BMI), Hemoglobin A1c (HbA1c), fasting and 2-hour glucose during an oral glucose tolerance test. RESULTS OC was significantly higher in children than adults (209.0 ± 12.1 vs. 41.0 ± 0.9 ng/ml, p<0.0001). In adults, OC was inversely associated (all p<0.001) with BMI (r=-0.2), HbA1c (r=-0.2), fasting glucose (r=-0.16), and 2-hour glucose (r=-0.21), while there were no significant associations in children. There was a stepwise decrease in OC with increasing dysglycemia in adults, normoglycemic (44.1 ± 1.3 ng/ml), prediabetic (39.3 ± 1.3 ng/ml), and T2D (31.8 ± 1.2 ng/ml), (p<0.0001), whereas there were no differences between normal and prediabetic youth (195.7 ± 16.1 vs. 194.7 ± 25.8 ng/ml, p=0.3). CONCLUSIONS OC was inversely associated with T2D risk in Latino adults; however, this pattern was not observed in children.
Collapse
Affiliation(s)
| | | | - Dawn K Coletta
- Mayo/ASU Center for Metabolic and Vascular Biology, Scottsdale, AZ.,School of Life Sciences, Arizona State University, Tempe, AZ
| | - Lawrence J Mandarino
- Mayo/ASU Center for Metabolic and Vascular Biology, Scottsdale, AZ.,School of Life Sciences, Arizona State University, Tempe, AZ
| | - Gabriel Q Shaibi
- Division of Endocrinology and Diabetes, Phoenix Children's Hospital, Phoenix, AZ.,Mayo/ASU Center for Metabolic and Vascular Biology, Scottsdale, AZ.,College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ
| |
Collapse
|
42
|
McLean CS, Mielke C, Cordova JM, Langlais PR, Bowen B, Miranda D, Coletta DK, Mandarino LJ. Gene and MicroRNA Expression Responses to Exercise; Relationship with Insulin Sensitivity. PLoS One 2015; 10:e0127089. [PMID: 25984722 PMCID: PMC4436215 DOI: 10.1371/journal.pone.0127089] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2014] [Accepted: 04/10/2015] [Indexed: 02/07/2023] Open
Abstract
Background Healthy individuals on the lower end of the insulin sensitivity spectrum also have a reduced gene expression response to exercise for specific genes. The goal of this study was to determine the relationship between insulin sensitivity and exercise-induced gene expression in an unbiased, global manner. Methods and Findings Euglycemic clamps were used to measure insulin sensitivity and muscle biopsies were done at rest and 30 minutes after a single acute exercise bout in 14 healthy participants. Changes in mRNA expression were assessed using microarrays, and miRNA analysis was performed in a subset of 6 of the participants using sequencing techniques. Following exercise, 215 mRNAs were changed at the probe level (Bonferroni-corrected P<0.00000115). Pathway and Gene Ontology analysis showed enrichment in MAP kinase signaling, transcriptional regulation and DNA binding. Changes in several transcription factor mRNAs were correlated with insulin sensitivity, including MYC, r=0.71; SNF1LK, r=0.69; and ATF3, r= 0.61 (5 corrected for false discovery rate). Enrichment in the 5’-UTRs of exercise-responsive genes suggested regulation by common transcription factors, especially EGR1. miRNA species of interest that changed after exercise included miR-378, which is located in an intron of the PPARGC1B gene. Conclusions These results indicate that transcription factor gene expression responses to exercise depend highly on insulin sensitivity in healthy people. The overall pattern suggests a coordinated cycle by which exercise and insulin sensitivity regulate gene expression in muscle.
Collapse
Affiliation(s)
- Carrie S. McLean
- School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America
| | - Clinton Mielke
- School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America
| | - Jeanine M. Cordova
- School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America
| | - Paul R. Langlais
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America
| | - Benjamin Bowen
- School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America
| | - Danielle Miranda
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America
| | - Dawn K. Coletta
- School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America
| | - Lawrence J. Mandarino
- School for the Science of Health Care Delivery, Arizona State University, Tempe, Arizona, United States of America
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America
- * E-mail:
| |
Collapse
|
43
|
Everman S, Mandarino LJ, Carroll CC, Katsanos CS. Effects of acute exposure to increased plasma branched-chain amino acid concentrations on insulin-mediated plasma glucose turnover in healthy young subjects. PLoS One 2015; 10:e0120049. [PMID: 25781654 PMCID: PMC4363593 DOI: 10.1371/journal.pone.0120049] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2014] [Accepted: 02/02/2015] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND Plasma branched-chain amino acids (BCAA) are inversely related to insulin sensitivity of glucose metabolism in humans. However, currently, it is not known whether there is a cause-and-effect relationship between increased plasma BCAA concentrations and decreased insulin sensitivity. OBJECTIVE To determine the effects of acute exposure to increased plasma BCAA concentrations on insulin-mediated plasma glucose turnover in humans. METHODS Ten healthy subjects were randomly assigned to an experiment where insulin was infused at 40 mU/m2/min (40U) during the second half of a 6-hour intravenous infusion of a BCAA mixture (i.e., BCAA; N = 5) to stimulate plasma glucose turnover or under the same conditions without BCAA infusion (Control; N = 5). In a separate experiment, seven healthy subjects were randomly assigned to receive insulin infusion at 80 mU/m2/min (80U) in association with the above BCAA infusion (N = 4) or under the same conditions without BCAA infusion (N = 3). Plasma glucose turnover was measured prior to and during insulin infusion. RESULTS Insulin infusion completely suppressed the endogenous glucose production (EGP) across all groups. The percent suppression of EGP was not different between Control and BCAA in either the 40U or 80U experiments (P > 0.05). Insulin infusion stimulated whole-body glucose disposal rate (GDR) across all groups. However, the increase (%) in GDR was not different [median (1st quartile - 3rd quartile)] between Control and BCAA in either the 40U ([199 (167-278) vs. 186 (94-308)] or 80 U ([491 (414-548) vs. 478 (409-857)] experiments (P > 0.05). Likewise, insulin stimulated the glucose metabolic clearance in all experiments (P < 0.05) with no differences between Control and BCAA in either of the experiments (P > 0.05). CONCLUSION Short-term exposure of young healthy subjects to increased plasma BCAA concentrations does not alter the insulin sensitivity of glucose metabolism.
Collapse
Affiliation(s)
- Sarah Everman
- Center for Metabolic and Vascular Biology, Arizona State University/Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America
| | - Lawrence J. Mandarino
- Center for Metabolic and Vascular Biology, Arizona State University/Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America
- School of Life Sciences, Arizona State University,Tempe, Arizona, United States of America
| | - Chad C. Carroll
- Department of Physiology, Midwestern University, Glendale, Arizona, United States of America
| | - Christos S. Katsanos
- Center for Metabolic and Vascular Biology, Arizona State University/Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America
- School of Life Sciences, Arizona State University,Tempe, Arizona, United States of America
- * E-mail:
| |
Collapse
|
44
|
DeMenna J, Puppala S, Chittoor G, Schneider J, Kim JY, Shaibi GQ, Mandarino LJ, Duggirala R, Coletta DK. Association of common genetic variants with diabetes and metabolic syndrome related traits in the Arizona Insulin Resistance registry: a focus on Mexican American families in the Southwest. Hum Hered 2014; 78:47-58. [PMID: 25060389 DOI: 10.1159/000363411] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2013] [Accepted: 05/06/2014] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND/AIMS The increased occurrence of type 2 diabetes and its clinical correlates is a global public health issue, and there are continued efforts to find its genetic determinant across ethnically diverse populations. The aims of this study were to determine the heritability of diabetes and metabolic syndrome phenotypes in the Arizona Insulin Resistance (AIR) registry and to perform an association analysis of common single nucleotide polymorphisms (SNPs) identified by GWAS with these traits. All study participants were Mexican Americans from the AIR registry. METHODS Metabolic, anthropometric, demographic and medical history information was obtained on the 667 individuals enrolled in the registry. RESULTS The heritability estimates were moderate to high in magnitude and significant, indicating that the AIR registry is well suited for the identification of genetic factors contributing to diabetes and the metabolic syndrome. From the 30 GWAS genes selected (some genes were represented by multiple SNPs), 20 SNPs exhibited associations with one or more of the diabetes related traits with nominal significance (p ≤ 0.05). In addition, 25 SNPs were nominally significantly associated with one or more of the metabolic phenotypes tested (p ≤ 0.05). Most notably, 5 SNPs from 5 genes [body mass index (BMI), hip circumference: rs3751812/FTO; fasting plasma glucose, hemoglobin A1c: rs4607517/GCK; very-low-density lipoprotein: rs10830963/MTNR1B; BMI: rs13266634/SLC30A8, and total cholesterol, low-density lipoprotein: rs7578597/THADA] were significantly associated with obesity, glycemic, and lipid phenotypes when using the multiple testing significance threshold of 0.0015. CONCLUSION These findings extend previous work on Mexican Americans to suggest that metabolic disease is strongly influenced by genetic background in this high-risk population.
Collapse
Affiliation(s)
- Jacob DeMenna
- School of Life Sciences, Arizona State University, Tempe, Ariz., USA
| | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Mielke C, Lefort N, McLean C, Cordova JM, Langlais PR, Bordner AJ, Te JA, Ozkan SB, Willis WT, Mandarino LJ. Adenine nucleotide translocase is acetylated in vivo in human muscle: Modeling predicts a decreased ADP affinity and altered control of oxidative phosphorylation. Biochemistry 2014; 53:3817-29. [PMID: 24884163 PMCID: PMC4067143 DOI: 10.1021/bi401651e] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Proteomics techniques have revealed that lysine acetylation is abundant in mitochondrial proteins. This study was undertaken (1) to determine the relationship between mitochondrial protein acetylation and insulin sensitivity in human skeletal muscle, identifying key acetylated proteins, and (2) to use molecular modeling techniques to understand the functional consequences of acetylation of adenine nucleotide translocase 1 (ANT1), which we found to be abundantly acetylated. Eight lean and eight obese nondiabetic subjects had euglycemic clamps and muscle biopsies for isolation of mitochondrial proteins and proteomics analysis. A number of acetylated mitochondrial proteins were identified in muscle biopsies. Overall, acetylation of mitochondrial proteins was correlated with insulin action (r = 0.60; P < 0.05). Of the acetylated proteins, ANT1, which catalyzes ADP-ATP exchange across the inner mitochondrial membrane, was acetylated at lysines 10, 23, and 92. The extent of acetylation of lysine 23 decreased following exercise, depending on insulin sensitivity. Molecular dynamics modeling and ensemble docking simulations predicted the ADP binding site of ANT1 to be a pocket of positively charged residues, including lysine 23. Calculated ADP-ANT1 binding affinities were physiologically relevant and predicted substantial reductions in affinity upon acetylation of lysine 23. Insertion of these derived binding affinities as parameters into a complete mathematical description of ANT1 kinetics predicted marked reductions in adenine nucleotide flux resulting from acetylation of lysine 23. Therefore, acetylation of ANT1 could have dramatic physiological effects on ADP-ATP exchange. Dysregulation of acetylation of mitochondrial proteins such as ANT1 therefore could be related to changes in mitochondrial function that are associated with insulin resistance.
Collapse
Affiliation(s)
- Clinton Mielke
- Center for Metabolic and Vascular
Biology, Arizona State University, Tempe, Arizona 85004, United States
| | - Natalie Lefort
- Center for Metabolic and Vascular
Biology, Arizona State University, Tempe, Arizona 85004, United States
| | - Carrie
G. McLean
- Center for Metabolic and Vascular
Biology, Arizona State University, Tempe, Arizona 85004, United States
| | - Jeanine M. Cordova
- Center for Metabolic and Vascular
Biology, Arizona State University, Tempe, Arizona 85004, United States
| | - Paul R. Langlais
- Division of Endocrinology, Mayo Clinic
in Arizona, Scottsdale, Arizona 85259, United
States
| | - Andrew J. Bordner
- Division of Endocrinology, Mayo Clinic
in Arizona, Scottsdale, Arizona 85259, United
States
| | - Jerez A. Te
- Division of Endocrinology, Mayo Clinic
in Arizona, Scottsdale, Arizona 85259, United
States
| | - S. Banu Ozkan
- Center for Metabolic and Vascular
Biology, Arizona State University, Tempe, Arizona 85004, United States
| | - Wayne T. Willis
- Center for Metabolic and Vascular
Biology, Arizona State University, Tempe, Arizona 85004, United States
| | - Lawrence J. Mandarino
- Center for Metabolic and Vascular
Biology, Arizona State University, Tempe, Arizona 85004, United States
- Division of Endocrinology, Mayo Clinic
in Arizona, Scottsdale, Arizona 85259, United
States
- Department of Medicine, Mayo
Clinic in Arizona, Scottsdale, Arizona 85259, United States
- Mayo Clinic in Arizona, 13400 E.
Shea Blvd., Scottsdale, AZ 85259. E-mail: . Phone: (480) 965-8365. Fax: (480) 965-6899
| |
Collapse
|
46
|
Xie X, Langlais P, Zhang X, Heckmann BL, Saarinen AM, Mandarino LJ, Liu J. Identification of a novel phosphorylation site in adipose triglyceride lipase as a regulator of lipid droplet localization. Am J Physiol Endocrinol Metab 2014; 306:E1449-59. [PMID: 24801391 PMCID: PMC4059987 DOI: 10.1152/ajpendo.00663.2013] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Adipose triglyceride lipase (ATGL), the rate-limiting enzyme for triacylglycerol (TG) hydrolysis, has long been known to be a phosphoprotein. However, the potential phosphorylation events that are involved in the regulation of ATGL function remain incompletely defined. Here, using a combinatorial proteomics approach, we obtained evidence that at least eight different sites of ATGL can be phosphorylated in adipocytes. Among them, Thr³⁷² resides within the hydrophobic region known to mediate lipid droplet (LD) targeting. Although it had no impact on the TG hydrolase activity, substitution of phosphorylation-mimic Asp for Thr³⁷² eliminated LD localization and LD-degrading capacity of ATGL expressed in HeLa cells. In contrast, mutation of Thr³⁷² to Ala gave a protein that bound LDs and functioned the same as the wild-type protein. In nonstimulated adipocytes, the Asp mutation led to decreased LD association and basal lipolytic activity of ATGL, whereas the Ala mutation produced opposite effects. Moreover, the LD translocation of ATGL upon β-adrenergic stimulation was also compromised by the Asp mutation. In accord with these findings, the Ala mutation promoted and the Asp mutation attenuated the capacity of ATGL to mediate lipolysis in adipocytes under both basal and stimulated conditions. Collectively, these studies identified Thr³⁷² as a novel phosphorylation site that may play a critical role in determining subcellular distribution as well as lipolytic action of ATGL.
Collapse
Affiliation(s)
- Xitao Xie
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Scottsdale, Arizona; HEALth Program, Mayo Clinic, Scottsdale, Arizona
| | | | - Xiaodong Zhang
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Scottsdale, Arizona; HEALth Program, Mayo Clinic, Scottsdale, Arizona
| | - Bradlee L Heckmann
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Scottsdale, Arizona; HEALth Program, Mayo Clinic, Scottsdale, Arizona; Mayo Graduate School, Rochester, Minnesota; and
| | - Alicia M Saarinen
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Scottsdale, Arizona; HEALth Program, Mayo Clinic, Scottsdale, Arizona
| | - Lawrence J Mandarino
- HEALth Program, Mayo Clinic, Scottsdale, Arizona; Division of Endocrinology, Mayo Clinic, Scottsdale, Arizona; Center for Metabolic and Vascular Biology, Arizona State University, Tempe, Arizona
| | - Jun Liu
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Scottsdale, Arizona; HEALth Program, Mayo Clinic, Scottsdale, Arizona; Division of Endocrinology, Mayo Clinic, Scottsdale, Arizona;
| |
Collapse
|
47
|
Miranda DN, Coletta DK, Mandarino LJ, Shaibi GQ. Increases in insulin sensitivity among obese youth are associated with gene expression changes in whole blood. Obesity (Silver Spring) 2014; 22:1337-44. [PMID: 24470352 PMCID: PMC4008712 DOI: 10.1002/oby.20711] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2013] [Accepted: 01/22/2014] [Indexed: 01/02/2023]
Abstract
OBJECTIVE Lifestyle intervention can improve insulin sensitivity in obese youth, yet few studies have examined the molecular signatures associated with these improvements. Therefore, the purpose of this study was to explore gene expression changes in whole blood that are associated with intervention-induced improvements in insulin sensitivity. METHODS Fifteen (7M/8F) overweight/obese (BMI percentile = 96.3 ± 1.1) Latino adolescents (15.0 ± 0.9 years) completed a 12-week lifestyle intervention that included weekly nutrition education and 180 minutes of moderate-vigorous exercise per week. Insulin sensitivity was estimated by an oral glucose tolerance test and the Matsuda Index. Global microarray analysis profiling from whole blood was performed to examine changes in gene expression and to explore biological pathways that were significantly changed in response to the intervention. RESULTS A total of 1,459 probes corresponding to mRNA transcripts (717 up, 742 down) were differentially expressed with a fold change ≥1.2. These genes were mapped within eight significant pathways identified, including insulin signaling, type 1 diabetes, and glycerophospholipid metabolism. Participants with increased insulin sensitivity exhibited five times the number of significant genes altered compared with nonresponders (1,144 vs. 230). CONCLUSIONS These findings suggest that molecular signatures from whole blood are associated with lifestyle-induced health improvements among high-risk Latino youth.
Collapse
Affiliation(s)
- Danielle N. Miranda
- Mayo Graduate School, Mayo Clinic, Rochester, MN
- Mayo/ASU Center for Metabolic and Vascular Biology, Arizona State University, Tempe, Arizona
| | - Dawn K. Coletta
- School of Life Science, Arizona State University, Tempe, AZ
- Mayo/ASU Center for Metabolic and Vascular Biology, Arizona State University, Tempe, Arizona
| | - Lawrence J. Mandarino
- School of Life Science, Arizona State University, Tempe, AZ
- Mayo/ASU Center for Metabolic and Vascular Biology, Arizona State University, Tempe, Arizona
| | - Gabriel Q. Shaibi
- Mayo/ASU Center for Metabolic and Vascular Biology, Arizona State University, Tempe, Arizona
- College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ
- Southwest Interdisciplinary Research Center, Arizona State University, Phoenix, AZ
| |
Collapse
|
48
|
Nair KS, Abel ED, Adler SG, Dyck PJ, Gardner TW, Haskins KM, Hotamisligil G, Jensen MD, Krook A, Mandarino LJ, Mitchell BD, Pessin JE, Sowers JR, Sussel L, Wareham N, Vella A. Time to look back and to look forward. Diabetes 2014; 63:1169-70. [PMID: 24651796 DOI: 10.2337/db14-0067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
49
|
Abstract
MOTIVATION Modern techniques have produced many sequence annotation databases and protein structure portals, but these Web resources are rarely integrated in ways that permit straightforward exploration of protein functional residues and their co-localization. RESULTS We have created the AMASS database, which maps 1D sequence annotation databases to 3D protein structures with an intuitive visualization interface. Our platform also provides an analysis service that screens mass spectrometry sequence data for post-translational modifications that reside in functionally relevant locations within protein structures. The system is built on the premise that functional residues such as active sites, cancer mutations and post-translational modifications within proteins may co-localize and share common functions. AVAILABILITY AND IMPLEMENTATION AMASS database is implemented with Biopython and Apache as a freely available Web server at amass-db.org.
Collapse
Affiliation(s)
- Clinton J Mielke
- Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA, The Center for Metabolic and Vascular Biology, Mayo Clinic, Scottsdale, AZ 85259, USA and Department of Biomedical Informatics, Arizona State University, Scottsdale, AZ 85259, USABiodesign Institute, Arizona State University, Tempe, AZ 85287, USA, The Center for Metabolic and Vascular Biology, Mayo Clinic, Scottsdale, AZ 85259, USA and Department of Biomedical Informatics, Arizona State University, Scottsdale, AZ 85259, USABiodesign Institute, Arizona State University, Tempe, AZ 85287, USA, The Center for Metabolic and Vascular Biology, Mayo Clinic, Scottsdale, AZ 85259, USA and Department of Biomedical Informatics, Arizona State University, Scottsdale, AZ 85259, USA
| | - Lawrence J Mandarino
- Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA, The Center for Metabolic and Vascular Biology, Mayo Clinic, Scottsdale, AZ 85259, USA and Department of Biomedical Informatics, Arizona State University, Scottsdale, AZ 85259, USA
| | - Valentin Dinu
- Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA, The Center for Metabolic and Vascular Biology, Mayo Clinic, Scottsdale, AZ 85259, USA and Department of Biomedical Informatics, Arizona State University, Scottsdale, AZ 85259, USA
| |
Collapse
|
50
|
Hussey SE, Sharoff CG, Garnham A, Yi Z, Bowen BP, Mandarino LJ, Hargreaves M. Effect of exercise on the skeletal muscle proteome in patients with type 2 diabetes. Med Sci Sports Exerc 2014; 45:1069-76. [PMID: 23274603 DOI: 10.1249/mss.0b013e3182814917] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
PURPOSE Exercise training alters protein abundance in the muscle of healthy individuals, but the effect of exercise on these proteins in patients with type 2 diabetes (T2D) is unknown. The aim of this study was to determine how exercise training alters the skeletal muscle proteome in patients with T2D. METHODS Biopsies of the vastus lateralis were obtained before and after 4 wk of exercise training in six patients with T2D (54 ± 4 yr; body mass index (BMI), 29 ± 2) and six age- and BMI-matched control subjects (48 ± 2; BMI, 28 ± 3) studied at the baseline. The proteins were identified and quantified using normalized spectral abundance factors by multidimensional high-resolution mass spectrometry. RESULTS Of the 1329 proteins assigned at the baseline, 438 were present in at least half of all the muscle samples; of these, 15 proteins differed significantly between the patients with T2D and control subjects (P < 0.05). In the diabetic patients, the exercise training altered the abundance of 17 proteins (P < 0.05). Key training adaptations included an increase in proteins of the malate-aspartate shuttle and citric acid cycle, reduced the abundance of glycolytic proteins, and altered the abundance of cytoskeleton proteins. CONCLUSION The data from this study support the ability of exercise training to alter the abundance of proteins that regulate metabolism and cytoskeletal structure in patients with T2D. These findings open new avenues for future research.
Collapse
Affiliation(s)
- Sophie E Hussey
- Department of Physiology, The University of Melbourne, Australia
| | | | | | | | | | | | | |
Collapse
|